Compounds > panduratin a
Page last updated: 2024-08-02 03:52:13

panduratin a

Description

panduratin A: isolated from Kaempferia pandurata; structure in first source [MeSH]

Panduratin A : no description available [CHeBI]

Cross-References

ID SourceID
PubMed CID6483648
CHEMBL ID379110
SCHEMBL ID464699
CHEBI ID66725
MeSH IDM0462880

Synonyms (26)

Synonym
methanone, (2,6-dihydroxy-4-methoxyphenyl)[(1r,2s,6r)-3-methyl-2-(3-methyl-2-butenyl)-6-phenyl-3-cyclohexen-1-yl]-
panduratin a
(2,6-dihydroxy-4-methoxy-phenyl)-[(1r,2s,6r)-3-methyl-2-(3-methylbut-2-enyl)-6-phenyl-cyclohex-3-en-1-yl]methanone
(-)-panduratin a
bdbm50185449
CHEMBL379110 ,
chebi:66725 ,
(2,6-dihydroxy-4-methoxyphenyl)-[(1r,2s,6r)-3-methyl-2-(3-methylbut-2-enyl)-6-phenylcyclohex-3-en-1-yl]methanone
unii-27n2bim2cr
methanone, (2,6-dihydroxy-4-methoxyphenyl)((1r,2s,6r)-3-methyl-2-(3-methyl-2-buten-1-yl)-6-phenyl-3-cyclohexen-1-yl)-, rel-
methanone, (2,6-dihydroxy-4-methoxyphenyl)((1r,2s,6r)-3-methyl-2-(3-methyl-2-butenyl)-6-phenyl-3-cyclohexen-1-yl)-, rel-
89837-52-5
methanone, (2,6-dihydroxy-4-methoxyphenyl)(3-methyl-2-(3-methyl-2-butenyl)-6-phenyl-3-cyclohexen-1-yl)-, (1alpha,2alpha,6beta)-
methanone, (2,6-dihydroxy-4-methoxyphenyl)(3-methyl-2-(3-methyl-2-butenyl)-6-phenyl-3-cyclohexen-1-yl)-, (1alpha,2alpha,6beta)-(+/-)-
(+/-)-panduratin a
27n2bim2cr ,
panoid
methanone, (2,6-dihydroxy-4-methoxyphenyl)(3-methyl-2-(3-methyl-2-butenyl)-6-phenyl-3-cyclohexen-1-yl)-, (1.alpha.,2.alpha.,6.beta.)-(+/-)-
panduratin a [inci]
methanone, (2,6-dihydroxy-4-methoxyphenyl)(3-methyl-2-(3-methyl-2-butenyl)-6-phenyl-3-cyclohexen-1-yl)-, (1.alpha.,2.alpha.,6.beta.)-
CCG-205910
SCHEMBL464699
DTXSID20237917
Q27135347
rel-(2,6-dihydroxy-4-methoxyphenyl)-[(1r,2s,6r)-3-methyl-2-(3-methylbut-2-enyl)-6-phenylcyclohex-3-en-1-yl]methanone
AKOS040753425

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.

Drug Classes (1)

ClassDescription
diarylheptanoidA family of plant metabolites with a common 1,7-diphenylheptane structural skeleton, carrying various substituents. They are mainly distributed in the roots, rhizomes and bark of Alpinia, Zingiber, Curcuma and Alnus species.

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverage (mM)Bioassay(s)
Genome polyproteinDengue virus 2 Thailand/16681/84IC5057.2800AID1847506
Genome polyproteinDengue virus 2 Thailand/16681/84Ki25.0000AID265726

Bioassays (101)

Assay IDTitleYearJournalArticle
AID1347396qHTS for inhibitors of Wild type Zika virus screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347351U-118MG Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347349Panc-1005 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347381Inflammasome Signaling qHTS Counterscreen: IL-1-beta AlphaLISA counterscreen against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347367qHTS for ATAD5 Agonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
ISSN: 1091-6490		Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347393qHTS for inhibitors of ER calcium dysfunction: SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347347UWB1.289 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347366KB-3-1 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347373qHTS for Constitutive Androstane Receptor (CAR) Agonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347362Diaphorse counterscreen qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347392qHTS for activators of dead-cell proteases activity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347355HEK-293 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347375qHTS for Hypoxia signaling pathway (HIF-1) agonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347372qHTS for Constitutive Androstane Receptor (CAR) Antagonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347361HEK293 12hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347358HPAF-II 12hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347391qHTS for activators of Nrf2/ARE signaling pathway screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347389qHTS assay for small molecule disruptors of mitochondrial membrane potential screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID134737610-beta competent E. coli microbial cell viability qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347363Firefly luciferase counterscreen qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347364KB-8-5-11 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347350SW1088 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347369MCF7 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347360HPAF-II 18hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347380qHTS for Antimalaria activity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347401Redox Reaction Profiling qHTS: Assay Interference Panel against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347356HPAF-II 24hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347348OV-SAHO Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347387Cytotoxicity qHTS for assessment of Hepg2 cells membrane integrity screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347359HEK293 24hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347388qHTS for Activators of p53 Stress Response Pathway screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347353A2780 Cisplatin Sensitive Ovarian Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347354UWB1.289-WTBRCA1 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347394Vero-766 cells viability qHTS against the NCATS CANVASS Library: Counterscreen for Zika virus inhibition assay2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347377DH5-alpha competent E. coli microbial cell viability qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347357HEK293 18hr Apoptosis Induction qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347378qHTS for H2AX Agonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347365SDT Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347371J3T Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347379qHTS for Inflammasome Signaling Inhibitors: IL-1-beta AlphaLISA screen against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347390Secretion counterscreen for inhibitors of the SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347402qHTS for inhibitors of Rabies Virus screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347352COV-362 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347345OV-KATE Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347400Viability qHTS for inhibitors of the SERCaMP assay screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347368G06 Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347346HPAF-II Cancer Cell Toxicity qHTS against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347374qHTS for Hypoxia signaling pathway (HIF-1) antagonists against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID1347370qHTS for ATAD5 Antagonist screened against the NCATS CANVASS Library2018ACS central science, Dec-26, Volume: 4, Issue:12
ISSN: 2374-7943		Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.
AID564817Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565007Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565016Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564806Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565020Antimicrobial activity against Porphyromonas gingivalis2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565008Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564820Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564809Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564816Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565015Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564813Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565024Antimicrobial activity against Propionibacterium acnes2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564833Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564822Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1847506Inhibition of DENV2 NS2B-NS3 protease using Boc-Gly-Arg-7-amino-4-methylcoumarin as substrate preincubated for 10 mins followed by substrate addition and incubated for 60 mins by fluorescence spectroscopy assay2021Bioorganic & medicinal chemistry, 11-01, Volume: 49ISSN: 1464-3391A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases.
AID564812Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565011Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID265721Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 240 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID565012Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565003Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564805Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564828Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564832Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564821Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565022Antimicrobial activity against Prevotella loescheii2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565027Bactericidal activity against Prevotella loescheii2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564829Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565021Antimicrobial activity against Streptococcus mutans2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID265724Inhibition of dengue2 virus NS2B/NS3 protease activity for Ac-Thr-Arg-Arg-MCA cleavage at 240 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID565004Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565019Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID564808Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID1713994Inhibition of monophenolase activity of tyrosinase in C57BL/6 mouse melan-a cells incubated for 72 hrs by bradford method2016Bioorganic & medicinal chemistry, 11-15, Volume: 24, Issue:22
ISSN: 1464-3391
AID565026Bactericidal activity against Streptococcus mutans2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565028Bactericidal activity against Prevotella intermedia2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID311568Cytotoxicity against human PANC1 cells assessed as cell viability2007Journal of natural products, Oct, Volume: 70, Issue:10
ISSN: 0163-3864		Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium.
AID265718Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 80 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID565023Antimicrobial activity against Prevotella intermedia2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565025Bactericidal activity against Porphyromonas gingivalis2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID565029Bactericidal activity against Propionibacterium acnes2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
ISSN: 1098-6596		In vitro activities of panduratin A against clinical Staphylococcus strains.
AID265722Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 400 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID265720Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 160 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID265717Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 40 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID265719Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 120 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID1873265Anti-obesity activity in male C57BL/6 mouse model of high-fat diet induced obesity assessed as body weight change at 50 mg/kg, po administered once a day for 8 weeks relative to control2022European journal of medicinal chemistry, Jul-05, Volume: 237ISSN: 1768-3254Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
AID1438026Cytotoxicity against human PANC1 cells in DMEM measured after 24 hrs by WST8 assay2017Journal of natural products, 01-27, Volume: 80, Issue:1
ISSN: 1520-6025
AID265726Inhibition of dengue2 virus NS3 protease2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID361394Induction of NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells assessed as drug level required to double specific enzyme activity after 48 hrs by MTT assay2002Journal of natural products, Nov, Volume: 65, Issue:11
ISSN: 0163-3864		Activity-guided isolation of constituents of Renealmia nicolaioides with the potential to induce the phase II enzyme quinone reductase.
AID1438024Antiausteritic activity against human PANC1 cells in nutrient-deprived medium measured after 24 hrs by WST8 assay2017Journal of natural products, 01-27, Volume: 80, Issue:1
ISSN: 1520-6025
AID265725Inhibition of dengue2 virus NS2B/NS3 protease activity for Ac-Thr-Arg-Arg-MCA cleavage at 400 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID265723Inhibition of dengue2 virus NS2B/NS3 protease activity for Ac-Thr-Arg-Arg-MCA cleavage at 120 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
ISSN: 0960-894X		Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (22.64)29.6817
2010's29 (54.72)24.3611
2020's12 (22.64)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.85%)5.53%
Reviews4 (7.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other49 (90.74%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
tetrahydrocurcumin
0
beta-diketone;
diarylheptanoid;
polyphenol		metabolite00low000000
myricanone
0
aromatic ether;
cyclic ketone;
diarylheptanoid;
methoxybenzenes;
phenols		antineoplastic agent;
plant metabolite		00low000000
dichamanetin
0
diarylheptanoidmetabolite00low000000
hirsutanone
0
diarylheptanoid00low000000
curcumin
0
aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger		00low000000
[3-amino-6-(4-methoxyphenyl)-2-thieno[2,3-b]pyridinyl]-(3,4-dimethoxyphenyl)methanone
0
diarylheptanoid00low000000
3-(3-fluoro-4-methoxyphenyl)-5-phenyl-7-furo[3,2-g][1]benzopyranone
0
diarylheptanoid00low000000
5-[(4-chlorophenyl)-oxomethyl]-4-hydroxy-6-[5-(2-nitrophenyl)-2-furanyl]-4-(trifluoromethyl)-1,3-diazinan-2-one
0
diarylheptanoid00low000000
gingerenone a
0
diarylheptanoid00low000000
bisdemethoxycurcumin
0
beta-diketone;
diarylheptanoid;
enone;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
metabolite		00low000000
hexahydrocurcumin
0
diarylheptanoid00low000000
5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-phenyl-3- heptanone
0
diarylheptanoid00low000000
demethoxycurcumin
0
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antineoplastic agent;
metabolite		00low000000
tetrahydroxycurcumin
0
beta-diketone;
catechols;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
neuroprotective agent;
plant metabolite		00low000000
1,7-bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one
0
diarylheptanoid;
enone;
phenols		plant metabolite00low000000
1,7-bis(4-hydroxyphenyl)hepta-4E-6E-dien-3-one
0
diarylheptanoid;
enone;
phenols		plant metabolite00low000000
1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one
0
diarylheptanoid00low000000
oregonin
0
diarylheptanoid00low000000
5,7-dimethoxy-8-[1-(4-methoxyphenyl)-3-(3-methyl-1-piperidinyl)-3-oxopropyl]-4-phenyl-1-benzopyran-2-one
0
diarylheptanoid00low000000
8-[1-[4-(dimethylamino)phenyl]-3-(3-methyl-1-piperidinyl)propyl]-5,7-dimethoxy-4-phenyl-1-benzopyran-2-one
0
diarylheptanoid00low000000
(E)-1,7-Bis(4-hydroxyphenyl)hept-4-en-3-one
0
diarylheptanoid00low000000
1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one
0
diarylheptanoid;
ketone;
phenols		plant metabolite00low000000
bromadiolone
0
diarylheptanoid00low000000
curcumin glucuronide
0
diarylheptanoid00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
alpha-hydroxyglutarate
0
2-hydroxydicarboxylic acid;
dicarboxylic fatty acid		metabolite;
mouse metabolite		00low000000
alpha-isopropylmalate
0
2-hydroxy carboxylic acid;
3-hydroxy carboxylic acid;
dicarboxylic acid		metabolite00low000000
acetoacetic acid
0
3-oxo fatty acid;
ketone body		metabolite00low000000
3-hydroxybenzyl alcohol
0
hydroxybenzyl alcohol;
phenols		metabolite00low000000
n-carbamoyl-beta-alanine
0
beta-alanine derivativemetabolite;
mouse metabolite		00low000000
ethylene glycol
0
ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin		00low000000
acetoin
0
methyl ketone;
secondary alpha-hydroxy ketone		metabolite00low000000
ammonium hydroxide
0
azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant		00low000000
benzyl alcohol
0
benzyl alcoholsantioxidant;
fragrance;
metabolite;
solvent		00low000000
carbon monoxide
0
carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent		00low000000
formic acid
0
monocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent		00low000000
4-hydroxymandelic acid
0
2-hydroxy carboxylic acid;
phenols		metabolite00low000000
aminoethylphosphonic acid
0
phosphonic acids;
primary amino compound;
zwitterion		human metabolite;
metabolite;
mouse metabolite		00low000000
hydrogen sulfide
0
gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride		Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent		00low000000
4-aminophenol
0
aminophenolallergen;
metabolite		00low000000
n(1)-acetylspermidine
0
acetylspermidineEscherichia coli metabolite;
metabolite		00low000000
aminocaproic acid
0
amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite		00low000000
dihydrouracil
0
pyrimidoneEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite		00low000000
dihydroxyacetone
0
ketotriose;
primary alpha-hydroxy ketone		antifungal agent;
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite		00low000000
dimethylamine
0
methylamines;
secondary aliphatic amine		metabolite00low000000
glycolic acid
0
2-hydroxy monocarboxylic acid;
primary alcohol		keratolytic drug;
metabolite		00low000000
hydantoin-5-propionic acid
0
imidazolidine-2,4-dione;
monocarboxylic acid		metabolite;
mouse metabolite		00low000000
niacinamide
0
pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor		00low000000
niacin
0
pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3		antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent		00low000000
orotic acid
0
pyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
oxaloacetic acid
0
C4-dicarboxylic acid;
oxo dicarboxylic acid		geroprotector;
metabolite		00low000000
porphobilinogen
0
aralkylamino compound;
dicarboxylic acid;
pyrroles		Escherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
1-propanol
0
propan-1-ols;
short-chain primary fatty alcohol		metabolite;
protic solvent		00low000000
trimethyloxamine
0
tertiary amine oxideEscherichia coli metabolite;
metabolite;
osmolyte		00low000000
6-hydroxymelatonin
0
acetamides;
tryptamines		metabolite;
mouse metabolite		00low000000
n-acetylphenylalanine
0
N-acetyl-amino acid;
phenylalanine derivative		antidepressant;
metabolite		00low000000
n-acetyltryptophan
0
N-acetyl-amino acid;
tryptophan derivative		metabolite00low000000
arecoline
0
enoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine		metabolite;
muscarinic agonist		00low000000
aristolochic acid i
0
aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin		00low000000
berberine
0
alkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound		antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker		00low000000
dibutyl phthalate
0
diester;
phthalate ester		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
environmental contaminant;
metabolite;
plasticiser;
teratogenic agent		00low000000
hydroxymethyltolbutamide
0
benzyl alcohols;
sulfonamide;
ureas		metabolite00low000000
methyl salicylate
0
benzoate ester;
methyl ester;
salicylates		flavouring agent;
insect attractant;
metabolite		00low000000
myristicin
0
organic molecular entitymetabolite00low000000
phenmetrazine
0
morpholinesmetabolite;
sympathomimetic agent		00low000000
phenylbutazone
0
pyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug		00low000000
safrole
0
benzodioxolesflavouring agent;
insecticide;
metabolite;
plant metabolite		00low000000
2,2'-thiodiethanol
0
aliphatic sulfide;
diol		antineoplastic agent;
antioxidant;
metabolite;
solvent		00low000000
sorbitol
0
glucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent		00low000000
alloxan
0
pyrimidonehyperglycemic agent;
metabolite		00low000000
thymidine
0
pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite		00low000000
glutamine
0
amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite		00low000000
allyl isothiocyanate
0
alkenyl isothiocyanate;
isothiocyanate		antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
lachrymator;
metabolite		00low000000
n-methyltryptamine
0
tryptamine alkaloid;
tryptamines		metabolite00low000000
4-deoxypyridoxine
0
hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine		metabolite00low000000
cycloserine
0
4-amino-1,2-oxazolidin-3-one;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic;
zwitterion		antiinfective agent;
antimetabolite;
antitubercular agent;
metabolite;
NMDA receptor agonist		00low000000
17-alpha-hydroxyprogesterone
0
17alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone		human metabolite;
metabolite;
mouse metabolite;
progestin		00low000000
mannitol
0
mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent		00low000000
phenacyl bromide
0
acetophenones;
alpha-bromoketone		metabolite00low000000
trichloroacetic acid
0
monocarboxylic acid;
organochlorine compound		carcinogenic agent;
metabolite;
mouse metabolite		00low000000
acrylic acid
0
alpha,beta-unsaturated monocarboxylic acidmetabolite00low000000
n-methylacetamide
0
acetamides;
monocarboxylic acid amide		metabolite00low000000
bis(4-hydroxyphenyl)sulfone
0
bisphenol;
sulfone		endocrine disruptor;
metabolite		00low000000
rotenone
0
organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin		00low000000
7-amino-4-hydroxy-2-naphthalenesulfonic acid
0
aminonaphthalenesulfonic acid;
naphthols		metabolite00low000000
methyl benzoate
0
benzoate ester;
methyl ester		insect attractant;
metabolite		00low000000
2-dichlorobenzene
0
dichlorobenzenehepatotoxic agent;
metabolite		00low000000
2,4-diaminotoluene
0
aminotoluenemetabolite00low000000
4-butyrolactone
0
butan-4-olidemetabolite;
neurotoxin		00low000000
sulfosalicylic acid
0
arenesulfonic acid;
benzoic acids;
phenols		metabolite00low000000
ethyl lactate
0
ethyl ester;
lactate ester;
secondary alcohol		metabolite00low000000
furaldehyde
0
aldehyde;
furans		Maillard reaction product;
metabolite		00low000000
thiophene-2-carboxaldehyde
0
aldehyde;
thiophenes		metabolite00low000000
alpha-resorcylic acid
0
dihydroxybenzoic acid;
resorcinols		metabolite00low000000
methylenebis(chloroaniline)
0
chloroanilinemetabolite00low000000
2-phenylethyl acetate
0
acetate estermetabolite;
Saccharomyces cerevisiae metabolite		00low000000
dibenzyl ether
0
benzyl ethermetabolite00low000000
ethyl propionate
0
propanoate estermetabolite00low000000
citronellal
0
aldehyde;
monoterpenoid		antifungal agent;
metabolite		00low000000
ethyl oenanthate
0
fatty acid ethyl estermetabolite00low000000
ethyl caprylate
0
fatty acid ethyl ester;
octanoate ester		metabolite00low000000
ethyl laurate
0
fatty acid ethyl estermetabolite00low000000
acetic anhydride
0
acyclic carboxylic anhydridemetabolite;
reagent		00low000000
ethyl isovalerate
0
fatty acid ethyl ester;
olefinic compound		metabolite00low000000
n-butyl n-butyrate
0
butyrate estermetabolite00low000000
ethyl decanoate
0
decanoate ester;
fatty acid ethyl ester		metabolite00low000000
methyl octanoate
0
fatty acid methyl ester;
octanoate ester		metabolite00low000000
2-octanone
0
methyl ketonemetabolite00low000000
hexylamine
0
primary aliphatic aminemetabolite00low000000
lauric acid methyl ester
0
dodecanoate ester;
fatty acid methyl ester		metabolite00low000000
octylamine
0
primary aliphatic aminemetabolite00low000000
n-decyl alcohol
0
decanol;
primary alcohol		metabolite;
pheromone;
protic solvent		00low000000
methyl palmitate
0
fatty acid methyl estermetabolite00low000000
maltol
0
4-pyranonesmetabolite00low000000
chloranil
0
1,4-benzoquinones;
organochlorine compound		EC 2.7.1.33 (pantothenate kinase) inhibitor;
metabolite		00low000000
dibenzoylmethane
0
aromatic ketone;
beta-diketone		antimutagen;
antineoplastic agent;
metabolite		00low000000
methyl anthranilate
0
benzoate esterflavouring agent;
metabolite		00low000000
benzyl acetate
0
acetate ester;
benzyl ester		metabolite00low000000
ethyl acetate
0
acetate ester;
ethyl ester;
volatile organic compound		EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite		00low000000
dibenzyl disulfide
0
organic aromatic compound;
organic disulfide		metabolite00low000000
mequinol
0
methoxybenzenes;
phenols		metabolite00low000000
gamma-resorcylic acid
0
dihydroxybenzoic acidmetabolite00low000000
kynuramine
0
kynurenamines;
primary amino compound		metabolite00low000000
5-methylpyrazole-3-carboxylic acid
0
monocarboxylic acid;
pyrazoles		metabolite00low000000
4-trifluoromethylaniline
0
(trifluoromethyl)benzenes;
substituted aniline		metabolite00low000000
methylguanidine
0
guanidinesEC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite;
uremic toxin		00low000000
liriodenine
0
alkaloid antibiotic;
cyclic ketone;
organic heteropentacyclic compound;
oxacycle;
oxoaporphine alkaloid		antifungal agent;
antimicrobial agent;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite		00low000000
plumbagin
0
hydroxy-1,4-naphthoquinone;
phenols		anticoagulant;
antineoplastic agent;
immunological adjuvant;
metabolite		00low000000
imperatorin
0
psoralensEC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite		00low000000
osthol
0
botanical anti-fungal agent;
coumarins		metabolite00low000000
Dillapiole
0
benzodioxolesmetabolite00low000000
coumaran
0
1-benzofuransmetabolite00low000000
1,3-propanediol
0
propane-1,3-diolsmetabolite;
protic solvent		00low000000
tridecanedioic acid
0
alpha,omega-dicarboxylic acidmetabolite00low000000
physcione
0
dihydroxyanthraquinoneanti-inflammatory agent;
antibacterial agent;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
hepatoprotective agent;
metabolite		00low000000
apiole
0
benzodioxolesmetabolite00low000000
flavone
0
flavonesmetabolite;
nematicide		00low000000
cetyl palmitate
0
hexadecanoate estermetabolite00low000000
n-amyl butyrate
0
butyrate estermetabolite00low000000
3-aminobutyric acid
0
amino acid zwitterion;
beta-amino acid;
monocarboxylic acid		metabolite00low000000
methyl lactate
0
lactate ester;
methyl ester		metabolite00low000000
paeonol
0
methoxybenzenes;
phenols		metabolite00low000000
2,2-dimethylbutyric acid
0
dimethylbutyric acidmetabolite00low000000
2-chloroacrylic acid
0
alpha,beta-unsaturated monocarboxylic acid;
chlorocarboxylic acid		metabolite00low000000
galactitol
0
hexitolEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite		00low000000
1-methyluracil
0
nucleobase analogue;
pyrimidone		metabolite00low000000
2-pyrrolidone
0
pyrrolidin-2-onesmetabolite;
polar solvent		00low000000
n-ethylacetamide
0
acetamidesmetabolite00low000000
6-methyluracil
0
pyrimidonemetabolite00low000000
3-methylglutaric acid
0
alpha,omega-dicarboxylic acidmetabolite00low000000
amyl acetate
0
acetate estermetabolite00low000000
dibenzothiophene 5-oxide
0
dibenzothiophenesmetabolite00low000000
2-acetamidoethanethiol
0
acetamidesmetabolite00low000000
2-hydroxyquinoxaline
0
hydroxyquinoxalinemetabolite00low000000
3,4-dihydroxyacetophenone
0
acetophenones;
catechols;
dihydroxyacetophenone		metabolite00low000000
methyl hippurate
0
glycine derivative;
methyl ester		metabolite00low000000
isobarbaloin
0
anthracenes;
C-glycosyl compound;
cyclic ketone;
phenols		laxative;
metabolite		00low000000
vincamine
0
alkaloid ester;
hemiaminal;
methyl ester;
organic heteropentacyclic compound;
vinca alkaloid		antihypertensive agent;
metabolite;
vasodilator agent		00low000000
methyl tert-butyl ether
0
etherfuel additive;
metabolite;
non-polar solvent		00low000000
4-octylphenol
0
phenolsmetabolite;
surfactant;
xenoestrogen		00low000000
dronabinol
0
benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic		00low000000
phenethyl isothiocyanate
0
isothiocyanateantineoplastic agent;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite		00low000000
2-methoxy-1,4-naphthoquinone
0
1,4-naphthoquinones;
enol ether		antimicrobial agent;
metabolite;
plant metabolite		00low000000
aviprin
0
furanocoumarinmetabolite00low000000
hydroxyphenytoin
0
imidazolidine-2,4-dione;
phenols		metabolite00low000000
squaric acid
0
alicyclic ketone;
carbon oxoacid		metabolite00low000000
methyl methanethiosulfonate
0
sulfonic acid derivative;
thiosulfonate ester		metabolite00low000000
arabinofuranosyluracil
0
N-glycosyl compoundmetabolite00low000000
6-aminonicotinic acid
0
aminonicotinic acid;
aminopyridine;
aromatic amine		metabolite00low000000
mannose
0
D-aldohexose;
D-mannose;
mannopyranose		metabolite00low000000
2,3-hexanedione
0
alpha-diketonemetabolite00low000000
tabersonine
0
alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		antineoplastic agent;
metabolite		00low000000
3,3-dimethylglutarate
0
alpha,omega-dicarboxylic acidmetabolite00low000000
raspberry ketone
0
methyl ketone;
phenols		androgen antagonist;
cosmetic;
flavouring agent;
fragrance;
hepatoprotective agent;
metabolite		00low000000
laurolitsine
0
aporphine alkaloid;
aromatic ether;
phenols		HIV-1 integrase inhibitor;
metabolite		00low000000
helenalin
0
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone		anti-inflammatory agent;
antineoplastic agent;
metabolite;
plant metabolite		00low000000
diethyl malate
0
malate estermetabolite00low000000
carbendazim
0
benzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		antifungal agrochemical;
antinematodal drug;
metabolite;
microtubule-destabilising agent		00low000000
glucoheptonate
0
carbohydrate acid;
monocarboxylic acid		metabolite00low000000
deslanoside
0
12beta-hydroxy steroid;
14beta-hydroxy steroid;
cardenolide glycoside;
tetrasaccharide derivative		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite		00low000000
streptozocin
0
N-acylglucosamine;
N-nitrosoureas		antimicrobial agent;
antineoplastic agent;
DNA synthesis inhibitor;
metabolite		00low000000
pedalitin
0
monomethoxyflavone;
tetrahydroxyflavone		EC 1.17.3.2 (xanthine oxidase) inhibitor;
metabolite		00low000000
ethyl nonanoate
0
fatty acid ethyl estermetabolite00low000000
ethyl hexanoate
0
fatty acid ethyl ester;
hexanoate ester		metabolite00low000000
butyl acetate
0
acetate estermetabolite00low000000
1,4-dioxane
0
dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent		00low000000
isoamyl acetate
0
acetate estermetabolite;
Saccharomyces cerevisiae metabolite		00low000000
ribostamycin
0
amino cyclitol glycoside;
aminoglycoside antibiotic		antibacterial drug;
antimicrobial agent;
metabolite		00low000000
tramadol
0
2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanoladrenergic uptake inhibitor;
antitussive;
capsaicin receptor antagonist;
delta-opioid receptor agonist;
kappa-opioid receptor agonist;
metabolite;
mu-opioid receptor agonist;
muscarinic antagonist;
nicotinic antagonist;
NMDA receptor antagonist;
opioid analgesic;
serotonergic antagonist;
serotonin uptake inhibitor		00low000000
6-pentylpyrone
0
2-pyranonesmetabolite00low000000
paclitaxel
0
taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent		00low000000
4-methylhistamine
0
aralkylamino compound;
imidazoles		histamine agonist;
metabolite		00low000000
perfosfamide
0
nitrogen mustard;
organochlorine compound;
peroxol;
phosphorodiamide		alkylating agent;
antineoplastic agent;
drug allergen;
immunosuppressive agent;
metabolite		00low000000
castanospermine
0
indolizidine alkaloidanti-HIV-1 agent;
anti-inflammatory agent;
EC 3.2.1.* (glycosidase) inhibitor;
metabolite		00low000000
pravastatin
0
3-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)		anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic		00low000000
3-methyl-2-butenal
0
enalmetabolite00low000000
ethyl 3-hydroxybutyrate
0
fatty acid ethyl estermetabolite00low000000
4,5-dimethyl-3-hydroxy-2(5h)-furanone
0
butenolidemetabolite00low000000
n-methylnicotinamide
0
pyridinecarboxamidemetabolite00low000000
3-aminoisobutyric acid
0
amino acid zwitterion;
beta-amino acid		metabolite00low000000
platanic acid
0
hydroxy monocarboxylic acid;
methyl ketone;
pentacyclic triterpenoid		anti-HIV agent;
metabolite		00low000000
2'-deoxyuridylic acid
0
deoxyuridine phosphate;
pyrimidine 2'-deoxyribonucleoside 5'-monophosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
gallocatechol
0
gallocatechinantioxidant;
metabolite;
radical scavenger		00low000000
1-methylinosine
0
inosinesmetabolite00low000000
dihydrobetulinic acid
0
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-HIV agent;
antileishmanial agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite		00low000000
bergenin
0
trihydroxybenzoic acidmetabolite00low000000
2-methoxyestradiol
0
17beta-hydroxy steroid;
3-hydroxy steroid		angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite		00low000000
3'-cmp
0
cytidine 3'-phosphate;
pyrimidine ribonucleoside 3'-monophosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
xanthoxyletin
0
coumarinsmetabolite00low000000
pinocembrin
0
(2S)-flavan-4-one;
dihydroxyflavanone		antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent		00low000000
orsellinic acid
0
dihydroxybenzoic acid;
resorcinols		fungal metabolite;
marine metabolite;
metabolite		00low000000
isoimperatorin
0
psoralensEC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite		00low000000
rotenolone
0
organic molecular entitymetabolite00low000000
seselin
0
coumarinsmetabolite00low000000
perillene
0
furans;
monoterpenoid		fragrance;
metabolite;
semiochemical		00low000000
glycine methyl ester
0
glycinyl estermetabolite00low000000
hexadecanamide
0
primary fatty amidemetabolite00low000000
benzocyclobutene
0
carbobicyclic compoundmetabolite00low000000
9-methyladenine
0
methyladeninemetabolite00low000000
n'-methyl-2-pyridone-5-carboxamide
0
methylpyridines;
pyridinecarboxamide;
pyridone		metabolite;
mouse metabolite		00low000000
1,3-dimethyluracil
0
pyrimidonemetabolite00low000000
3-methoxysalicylic acid
0
methoxysalicylic acidmetabolite00low000000
1,3-dimethyluric acid
0
oxopurinemetabolite00low000000
leucyltyrosine
0
dipeptidemetabolite00low000000
3-methylxanthine
0
3-methylxanthinemetabolite00low000000
leucyl-glycyl-glycine
0
tripeptidemetabolite00low000000
acetylleucine
0
L-leucine derivative;
N-acetyl-L-amino acid		metabolite00low000000
n-benzoylalanine, (dl-ala)-isomer
0
alanine derivative;
N-acyl-amino acid		metabolite00low000000
dipropylacetamide
0
fatty amidegeroprotector;
metabolite;
teratogenic agent		00low000000
masoprocol
0
nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite		00low000000
7-methyladenine
0
methyladeninemetabolite00low000000
acetylisoniazid
0
carbohydrazidemetabolite00low000000
illimaquinone
0
monohydroxy-1,4-benzoquinones;
prenylquinone		metabolite00low000000
coptisine
0
alkaloidmetabolite00low000000
betulin
0
diol;
pentacyclic triterpenoid		analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite		00low000000
narciclasine
0
phenanthridinesmetabolite00low000000
lividomycin
0
lividomycinsmetabolite00low000000
dmp 323
0
diazepanone;
ureas		anti-HIV agent;
metabolite		00low000000
eupolauridine
0
naphthyridine derivativemetabolite00low000000
zaluzanin C
0
gamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
secondary alcohol;
sesquiterpene lactone		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite		00low000000
2-aminonicotinic acid
0
aminonicotinic acid;
aminopyridine		metabolite00low000000
(-)-catechin
0
catechinmetabolite00low000000
dehydrocostus lactone
0
gamma-lactone;
guaiane sesquiterpenoid;
organic heterotricyclic compound;
sesquiterpene lactone		antimycobacterial drug;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 2 inhibitor;
metabolite;
trypanocidal drug		00low000000
Tormentic acid
0
triterpenoidmetabolite00low000000
pinobanksin
0
secondary alpha-hydroxy ketone;
trihydroxyflavanone		antimutagen;
antioxidant;
metabolite		00low000000
sigmoidin a
0
4'-hydroxyflavanones;
tetrahydroxyflavanone		anti-inflammatory agent;
anti-obesity agent;
antibacterial agent;
metabolite;
radical scavenger		00low000000
xanthosine 5'-triphosphate
0
purine ribonucleoside 5'-monophosphate;
xanthosine 5'-phosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
monotropein
0
beta-D-glucoside;
cyclopentapyran;
iridoid monoterpenoid;
monocarboxylic acid;
monosaccharide derivative		anti-inflammatory agent;
metabolite		00low000000
glycyl-histidyl-lysine
0
tripeptidechelator;
hepatoprotective agent;
metabolite;
vulnerary		00low000000
homoeriodictyol
0
3'-methoxyflavanones;
4'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		flavouring agent;
metabolite		00low000000
arjunolic acid
0
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		antibacterial agent;
antifungal agent;
antioxidant;
metabolite		00low000000
oxazolidin-2-one
0
carbamate ester;
oxazolidinone		metabolite00low000000
monoethyl phthalate
0
ethyl ester;
phthalic acid monoester		metabolite00low000000
methylimidazoleacetic acid
0
imidazoles;
monocarboxylic acid		GABA agonist;
metabolite		00low000000
2-(2-aminoethyl)pyridine
0
aminoalkylpyridine;
primary amine		histamine agonist;
metabolite		00low000000
xanthurenic acid 8-methyl ether
0
aromatic ether;
monohydroxyquinoline;
quinolinemonocarboxylic acid		carcinogenic agent;
metabolite;
mouse metabolite		00low000000
methyl orsellinate
0
hydroxybenzoic acidmetabolite00low000000
2,2-di(4-methacryloxyphenyl)propane
0
bisphenol;
enoate ester		metabolite00low000000
sofosbuvir
0
aminopyrimidine;
aromatic carboxylic acid;
nucleobase analogue;
pyrimidone		metabolite00low000000
3-methyluracil
0
nucleobase analogue;
pyrimidone		metabolite00low000000
1-methylcytosine
0
aminopyrimidine;
methylcytosine;
pyrimidone		metabolite00low000000
leucyl-alanine
0
dipeptidemetabolite00low000000
leucyl-leucyl-leucine
0
tripeptidemetabolite00low000000
3,4-dihydroxyphenylethanol
0
catechols;
primary alcohol		antineoplastic agent;
antioxidant;
metabolite		00low000000
3,7-dimethyluric acid
0
oxopurinemetabolite;
mouse metabolite		00low000000
alanylproline
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
d-biotin-d-sulfoxide
0
biotins;
sulfoxide		metabolite00low000000
biotin sulfone
0
biotins;
sulfone		metabolite00low000000
asperuloside
0
acetate ester;
beta-D-glucoside;
gamma-lactone;
iridoid monoterpenoid;
monosaccharide derivative		metabolite00low000000
primin
0
1,4-benzoquinonesallergen;
antifeedant;
antimicrobial agent;
hapten;
metabolite		00low000000
2-(hydroxymethyl)anthraquinone
0
anthraquinonemetabolite00low000000
tyrosylleucine
0
dipeptidemetabolite00low000000
o-methylserine
0
L-serine derivative;
non-proteinogenic L-alpha-amino acid		metabolite00low000000
cinchonine
0
(8xi)-cinchonan-9-ol;
cinchona alkaloid		metabolite00low000000
aucubin
0
organic molecular entitymetabolite00low000000
catalpol
0
organic molecular entitymetabolite00low000000
3,4-dihydroxyphenylglycol
0
catechols;
tetrol		metabolite;
mouse metabolite		00low000000
2-methylhistamine
0
aralkylamino compound;
imidazoles		histamine agonist;
metabolite		00low000000
2-methylhippuric acid
0
N-acylglycinemetabolite00low000000
taraxerol
0
pentacyclic triterpenoid;
secondary alcohol		metabolite00low000000
alpha-peltatin
0
furonaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols		antineoplastic agent;
metabolite		00low000000
3-acetyllupeol
0
organic molecular entitymetabolite00low000000
lupenone
0
triterpenoidmetabolite00low000000
glycyltryptophan
0
dipeptidemetabolite00low000000
monocerin
0
hydroxybenzoic acidmetabolite00low000000
propionyl-coenzyme a
0
acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
alpha-hydroxyisocaproic acid
0
2-hydroxy fatty acid;
branched-chain fatty acid		metabolite00low000000
totarol
0
diterpenoidmetabolite00low000000
taraxerone
0
scalarane sesterterpenoidmetabolite00low000000
prunin protein, prunus
0
(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
flavanone 7-O-beta-D-glucoside;
monosaccharide derivative		antibacterial agent;
antilipemic drug;
hypoglycemic agent;
metabolite		00low000000
uvaol
0
triterpenoidmetabolite00low000000
glycyltyrosine
0
dipeptidemetabolite00low000000
glycylleucine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
alanyltyrosine
0
dipeptidemetabolite00low000000
glycyl-l-phenylalanine
0
dipeptide zwitterion;
dipeptide		human metabolite;
metabolite		00low000000
digoxigenin-mono(digitoxoside)
0
cardenolide glycoside;
digitoxoside;
monosaccharide derivative;
steroid saponin		metabolite00low000000
thiazolidine-4-carboxylic acid, (r)-isomer
0
thiazolidinemonocarboxylic acid;
thioproline		geroprotector;
metabolite		00low000000
5,6-dihydrothymine
0
pyrimidonehuman metabolite;
metabolite;
mouse metabolite		00low000000
dehydroabietic acid
0
abietane diterpenoid;
carbotricyclic compound;
monocarboxylic acid		allergen;
metabolite		00low000000
palmitone
0
dialkyl ketoneanticonvulsant;
metabolite		00low000000
1-methylthymine
0
methylthyminemetabolite00low000000
imidazoleacetic acid
0
imidazoles;
monocarboxylic acid		metabolite;
mouse metabolite		00low000000
1-methylguanosine
0
methylguanosinemetabolite00low000000
alanylphenylalanine
0
dipeptidemetabolite00low000000
murrayanine
0
carbazolesmetabolite00low000000
girinimbine
0
carbazolesmetabolite00low000000
tryptophylglycine
0
dipeptidemetabolite00low000000
canthin-6-one
0
enone;
indole alkaloid;
organic heterotetracyclic compound		antimycobacterial drug;
metabolite		00low000000
glycylaspartic acid
0
dipeptidemetabolite00low000000
4-methylhippuric acid
0
N-acylglycinemetabolite00low000000
delta(9)-tetrahydrocannabinolic acid
0
benzochromene;
diterpenoid;
hydroxy monocarboxylic acid;
phytocannabinoid;
polyketide		anti-inflammatory agent;
biomarker;
metabolite;
neuroprotective agent		00low000000
3-methylhippuric acid
0
N-acylglycinemetabolite00low000000
n-glycylglutamic acid
0
dipeptidemetabolite00low000000
n-caproylglycine
0
N-acylglycinemetabolite00low000000
diosgenin
0
3beta-sterol;
hexacyclic triterpenoid;
sapogenin;
spiroketal		antineoplastic agent;
antiviral agent;
apoptosis inducer;
metabolite		00low000000
s-2-aminoethyl cysteine
0
L-cysteine thioether;
non-proteinogenic L-alpha-amino acid		EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor;
metabolite;
protein synthesis inhibitor		00low000000
4-hydroxycyclophosphamide
0
nitrogen mustard;
organochlorine compound;
phosphorodiamide		alkylating agent;
metabolite		00low000000
alpha-glutamyltryptophan
0
dipeptideangiogenesis modulating agent;
antineoplastic agent;
immunomodulator;
metabolite		00low000000
malabaricone c
0
butanonemetabolite00low000000
loliolide
0
benzofuransmetabolite00low000000
tuberostemonine
0
alkaloidmetabolite00low000000
pyrrole-3-carboxylic acid
0
pyrrolecarboxylic acidmetabolite;
Penicillium metabolite		00low000000
histidylglycine
0
dipeptidemetabolite00low000000
histidinoalanine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
cinchonidine
0
(8xi)-cinchonan-9-ol;
cinchona alkaloid		metabolite00low000000
quillaic acid
0
aldehyde;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory agent;
metabolite		00low000000
p-methoxy-n-methylphenethylamine
0
aromatic ether;
secondary amino compound		metabolite00low000000
ecgonine methyl ester
0
methyl ester;
tertiary amino compound;
tropane alkaloid		analgesic;
central nervous system depressant;
metabolite;
mouse metabolite;
opioid analgesic;
peripheral nervous system drug		00low000000
n-acetylcytidine
0
acetamides;
cytidines;
secondary carboxamide		metabolite00low000000
4-hydroxydebrisoquin
0
carboxamidine;
isoquinolines;
secondary alcohol		metabolite00low000000
hypotaurine
0
aminosulfinic acid;
zwitterion		human metabolite;
metabolite;
mouse metabolite		00low000000
hc toxin
0
homodetic cyclic peptide;
tetrapeptide		antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
metabolite;
phytotoxin		00low000000
epicatechin gallate
0
catechin;
gallate ester;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite		00low000000
versiconal hemiacetal acetate
0
acetate ester;
anthrafuran;
lactol;
palmitoyl amino acid;
polyphenol		metabolite00low000000
selenodiglutathione
0
glutathione derivative;
thioselenide		Escherichia coli metabolite;
metabolite		00low000000
coprine
0
cyclopropanes;
dicarboxylic acid monoamide;
L-glutamine derivative;
non-proteinogenic L-alpha-amino acid		EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
metabolite;
mycotoxin		00low000000
aristolochic acid ii
0
aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin		00low000000
exp3174
0
biphenylyltetrazole;
imidazoles;
organochlorine compound		metabolite00low000000
ribonolactone
0
butan-4-olide;
ribonolactone		metabolite00low000000
sulfamethoxazole hydroxylamine
0
isoxazoles;
sulfonamide		allergen;
metabolite		00low000000
androsterone glucuronide
0
beta-D-glucosiduronic acid;
steroid glucosiduronic acid		human metabolite;
metabolite;
mouse metabolite		00low000000
tephrosin
0
aromatic ether;
cyclic ketone;
organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
pesticide		00low000000
sapintoxin d
0
phorbol ester;
tertiary alpha-hydroxy ketone		fluorescent probe;
metabolite		00low000000
amarogentin
0
monosaccharide derivative;
secoiridoid glycoside		EC 5.99.1.2 (DNA topoisomerase) inhibitor;
metabolite		00low000000
taraxasterol
0
pentacyclic triterpenoid;
secondary alcohol		anti-inflammatory agent;
metabolite		00low000000
asiatic acid
0
monocarboxylic acid;
pentacyclic triterpenoid;
triol		angiogenesis modulating agent;
metabolite		00low000000
flavoglaucin
0
hydroquinonesmetabolite00low000000
1-(6-hydroxy-2-isopropenyl-1-benzofuran-5-yl)-1-ethanone
0
benzofuransmetabolite00low000000
dioscin
0
hexacyclic triterpenoid;
spiroketal;
spirostanyl glycoside;
trisaccharide derivative		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 1.14.18.1 (tyrosinase) inhibitor;
hepatoprotective agent;
metabolite		00low000000
maculosin
0
dipeptide;
homodetic cyclic peptide;
phenols;
pyrrolopyrazine		metabolite00low000000
n(4)-methylcytosine
0
aminopyrimidine;
methylcytosine;
pyrimidone		metabolite00low000000
n-acetylputrescine
0
N-monoacetylalkane-alpha,omega-diamine;
N-substituted putrescine		metabolite;
mouse metabolite		00low000000
4'-demethylpodophyllotoxin
0
furonaphthodioxole;
organic heterotetracyclic compound;
phenols		metabolite00low000000
lysicamine
0
alkaloid antibiotic;
oxoaporphine alkaloid		metabolite00low000000
celastrol
0
monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite		00low000000
procyanidin b2
0
biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		antioxidant;
metabolite		00low000000
aromadedrin
0
4'-hydroxyflavanones;
dihydroflavonols;
secondary alpha-hydroxy ketone;
tetrahydroxyflavanone		metabolite00low000000
3-methylthymine
0
methylthymine;
pyrimidone		metabolite00low000000
tyrosyl-glycyl-glycine
0
tripeptide zwitterion;
tripeptide		metabolite00low000000
cyclic adp-ribose
0
cyclic purine nucleotide;
nucleotide-sugar		metabolite;
ryanodine receptor agonist		00low000000
glycylglutamine
0
dipeptide zwitterion;
dipeptide		metabolite;
protective agent		00low000000
alanylglutamine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
naadp
0
nicotinic acid dinucleotidecalcium channel agonist;
metabolite;
signalling molecule		00low000000
procyanidin b5
0
biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		metabolite00low000000
proanthocyanidin a2
0
hydroxyflavan;
proanthocyanidin		angiogenesis modulating agent;
anti-HIV agent;
antioxidant;
metabolite		00low000000
dihydrosanguinarine
0
benzophenanthridine alkaloidantifungal agent;
metabolite		00low000000
tetrahydrocurcumin
0
beta-diketone;
diarylheptanoid;
polyphenol		metabolite00low000000
eriodictyol 7-glucuronide
0
3'-hydroxyflavonoid;
beta-D-glucosiduronic acid		EC 1.1.1.21 (aldehyde reductase) inhibitor;
metabolite		00low000000
beta-lipotropin, gln(9)-
0
catechols;
crown compound;
macrocyclic lactone		bacterial metabolite;
metabolite		00low000000
4-nitrososulfamethoxazole
0
isoxazoles;
nitroso compound;
sulfonamide		allergen;
metabolite		00low000000
protosappanin a
0
catecholsmetabolite00low000000
3,3'-neotrehalosadiamine
0
amino disaccharide;
glycosyl glycoside derivative		antimicrobial agent;
metabolite		00low000000
salvinorin a
0
organic heterotricyclic compound;
organooxygen compound		metabolite;
oneirogen		00low000000
cyanidin
0
5-hydroxyanthocyanidinantioxidant;
metabolite;
neuroprotective agent		00low000000
yakuchinone-a
0
ketone;
monomethoxybenzene;
phenols		antineoplastic agent;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite		00low000000
marsupsin
0
1-benzofurans;
aromatic ether;
polyphenol		antilipemic drug;
hypoglycemic agent;
metabolite		00low000000
6,6'-bieckol
0
aromatic ether;
oxacycle;
phlorotannin		anti-HIV-1 agent;
metabolite;
radical scavenger		00low000000
3-methylcytosine
0
aminopyrimidine;
methylcytosine;
pyrimidone		metabolite00low000000
eckol
0
phlorotanninantioxidant;
metabolite		00low000000
procyanidin b3
0
biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
metabolite		00low000000
aclacinomycin
0
aminoglycoside;
anthracycline;
deoxy hexoside;
methyl ester;
monosaccharide derivative;
phenols;
polyketide;
tertiary alcohol;
tetracenequinones;
zwitterion		antimicrobial agent;
antineoplastic agent;
metabolite		00low000000
phenylalanylarginine
0
dipeptidemetabolite00low000000
prolylarginine
0
dipeptidemetabolite00low000000
5-methoxytryptophan
0
L-alpha-amino acid zwitterion;
L-tryptophan derivative		metabolite00low000000
phenylalanylglutamate
0
dipeptidemetabolite00low000000
aspartylglycine
0
dipeptidemetabolite00low000000
aspartylglutamate
0
dipeptidemetabolite00low000000
5-hydroxypipecolic acid
0
piperidinemonocarboxylic acidmetabolite00low000000
prolyl-tyrosine
0
dipeptidemetabolite00low000000
histidylproline
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
phenylalanyl-glycyl-glycine
0
tripeptidemetabolite00low000000
leucylarginine
0
dipeptidemetabolite00low000000
pendolmycin
0
indolesmetabolite00low000000
atractylenolide iii
0
naphthofuranmetabolite00low000000
malvidin
0
5-hydroxyanthocyanidinbiological pigment;
metabolite		00low000000
5-hydroxytryptoline
0
beta-carbolinesmetabolite00low000000
perlolyrine
0
organic molecular entitymetabolite00low000000
endocrocin
0
monocarboxylic acid;
phenols;
trihydroxyanthraquinone		metabolite00low000000
sulochrin
0
benzophenones;
carboxylic ester;
phenols		metabolite00low000000
i-677
0
L-serine derivative;
non-proteinogenic L-alpha-amino acid		antimetabolite;
antimicrobial agent;
antineoplastic agent;
metabolite		00low000000
isohomovanillic acid
0
aromatic ether;
phenols;
phenylacetic acids		metabolite00low000000
4-amino-2-methoxypyrimidine
0
aminopyrimidine;
aromatic ether;
methylcytosine		metabolite00low000000
asimilobine
0
aporphine alkaloidmetabolite00low000000
aristolochic acid D
0
aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
nephrotoxin;
toxin		00low000000
leukodopachrome
0
hydroxy monocarboxylic acid;
indoles		metabolite00low000000
ampelopsin
0
dihydromyricetin;
secondary alpha-hydroxy ketone		antineoplastic agent;
antioxidant;
metabolite		00low000000
pinusolide
0
diterpene lactonemetabolite00low000000
2,4,5-trihydroxypentanoic acid gamma-lactone
0
ribonolactonemetabolite00low000000
hydroxysitosterol
0
3beta-hydroxy-Delta(5)-steroid;
7alpha-hydroxy steroid		metabolite;
plant metabolite		00low000000
jolkinolide a
0
diterpene lactonemetabolite00low000000
jolkinolide b
0
diterpene lactonemetabolite00low000000
1-o-hexadecyl-2-lyso-glycero-3-phosphorylcholine
0
1-alkyl-sn-glycero-3-phosphocholine;
lysophosphatidylcholine O-16:0		metabolite00low000000
isovitexin
0
C-glycosyl compound;
trihydroxyflavone		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite		00low000000
dopamine quinone
0
1,2-benzoquinones;
primary amino compound		metabolite00low000000
platycodin d
0
triterpenoid saponinmetabolite00low000000
frenolicin b
0
benzoisochromanequinone;
p-quinones		metabolite00low000000
4-oxopentanal
0
ketoaldehydemetabolite00low000000
my 12-62c
0
monohydroxyquinoline;
quinolone		antibacterial agent;
iron chelator;
metabolite;
signalling molecule		00low000000
3,4-dihydroxyphenylpyruvic acid
0
2-oxo monocarboxylic acidmetabolite00low000000
proximadiol
0
eudesmane sesquiterpenoidmetabolite00low000000
aristolochic acid c
0
aristolochic acids;
aromatic ether;
C-nitro compound;
cyclic acetal;
monocarboxylic acid;
organic heterotetracyclic compound		carcinogenic agent;
metabolite;
mutagen;
nephrotoxin;
toxin		00low000000
phenylacetyl-coenzyme a
0
acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
taxusin
0
acetate ester;
carbotricyclic compound;
taxane diterpenoid		metabolite00low000000
confertin
0
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
pseudoguaianolide		anti-inflammatory agent;
metabolite;
plant metabolite		00low000000
beta-methylcrotonylglycine
0
N-acylglycinemetabolite00low000000
tracheloside
0
glycoside;
lignan		metabolite00low000000
maytenonic acid
0
triterpenoidmetabolite00low000000
procyanidin C1
0
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
lipoxygenase inhibitor;
metabolite		00low000000
3-methyleneindolenine
0
indolesmetabolite00low000000
isopulegol
0
p-menthane monoterpenoidmetabolite00low000000
kadsurin
0
tanninmetabolite00low000000
lysylproline
0
dipeptidemetabolite00low000000
5-o-methylembelin
0
enol ether;
monohydroxy-1,4-benzoquinones		antileishmanial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
metabolite		00low000000
dihydrodaidzein
0
hydroxyisoflavanonemetabolite00low000000
4'-o-methylepigallocatechin
0
catechinmetabolite00low000000
corynoline
0
benzophenanthridine alkaloid;
cyclic acetal;
isoquinolines;
organic heterohexacyclic compound;
secondary alcohol		antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hepatoprotective agent;
metabolite		00low000000
limonin
0
epoxide;
furans;
hexacyclic triterpenoid;
lactone;
limonoid;
organic heterohexacyclic compound		inhibitor;
metabolite;
volatile oil component		00low000000
dichamanetin
0
diarylheptanoidmetabolite00low000000
brevianamide f
0
dipeptide;
indoles;
pyrrolopyrazine		metabolite00low000000
ergolide
0
acetate ester;
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		anti-inflammatory agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor;
plant metabolite		00low000000
4-sulfocatechol
0
dihydroxybenzenesulfonic acidmetabolite00low000000
histidylleucine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
7-methoxyheptaphylline
0
carbazolesmetabolite00low000000
phenylalanylserine
0
dipeptidemetabolite00low000000
phellamurin
0
4'-hydroxyflavanones;
beta-D-glucoside;
dihydroflavonols;
flavanone glycoside;
monosaccharide derivative;
trihydroxyflavanone		metabolite00low000000
prolylglutamic acid
0
dipeptidemetabolite00low000000
nantenine
0
oxoaporphine alkaloidmetabolite00low000000
hydrastine
0
isoquinolinesmetabolite00low000000
butyrylcarnitine
0
O-butanoylcarnitine;
saturated fatty acyl-L-carnitine		metabolite00low000000
2-hydroxyestradiol
0
17beta-hydroxy steroid;
2-hydroxy steroid		carcinogenic agent;
human metabolite;
metabolite;
mouse metabolite;
prodrug		00low000000
aromaticin
0
cyclic ketone;
gamma-lactone;
organic heterotricyclic compound;
sesquiterpene lactone		anti-inflammatory agent;
metabolite;
plant metabolite		00low000000
acivicin
0
isoxazoles;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		antileishmanial agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor;
glutamine antagonist;
metabolite		00low000000
n-methylcorydaldine
0
quinolonemetabolite00low000000
2-amino-3,3-dimethylbutanoic acid
0
non-proteinogenic alpha-amino acidmetabolite00low000000
pentabromopseudilin
0
pyrrolesmetabolite00low000000
rocaglamide
0
monocarboxylic acid amide;
monomethoxybenzene;
organic heterotricyclic compound		antileishmanial agent;
antineoplastic agent;
metabolite		00low000000
dentatin
0
coumarinsmetabolite00low000000
acronine
0
acridone derivatives;
alkaloid		antineoplastic agent;
metabolite		00low000000
enmein
0
delta-lactonemetabolite00low000000
5-aminonicotinic acid
0
aminonicotinic acid;
aminopyridine;
aromatic amine		metabolite00low000000
pomolic acid
0
triterpenoidmetabolite00low000000
aglafoline
0
methyl ester;
organic heterotricyclic compound		metabolite;
platelet aggregation inhibitor		00low000000
isomaltose
0
glycosylglucosehuman metabolite;
metabolite;
mouse metabolite		00low000000
deoxyglucose
0
2-deoxy-D-glucosemetabolite00low000000
vestitone
0
(3R)-2'-hydroxyisoflavanones;
hydroxyisoflavanone;
methoxyisoflavanone		antibacterial agent;
metabolite		00low000000
pantetheine
0
pantetheines;
thiol		human metabolite;
metabolite;
mouse metabolite		00low000000
salicin
0
aromatic primary alcohol;
aryl beta-D-glucoside;
benzyl alcohols		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug		00low000000
taxifolin
0
taxifolinmetabolite00low000000
n-formylmethionine
0
L-methionine derivative;
N-formyl amino acid;
proteinogenic amino acid		metabolite00low000000
fucose
0
deoxygalactosemetabolite00low000000
saponarin
0
C-glycosyl compound;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		metabolite00low000000
hippeastrine
0
delta-lactone;
indole alkaloid;
organic heteropentacyclic compound;
secondary alcohol		antineoplastic agent;
metabolite		00low000000
cyanidin 3-o-beta-d-glucopyranoside
0
anthocyanin cation;
beta-D-glucoside;
monosaccharide derivative		metabolite00low000000
silychristin
0
1-benzofurans;
aromatic ether;
flavonolignan;
polyphenol;
secondary alpha-hydroxy ketone		lipoxygenase inhibitor;
metabolite;
prostaglandin antagonist;
radical scavenger		00low000000
peonidin
0
5-hydroxyanthocyanidinantineoplastic agent;
antioxidant;
apoptosis inducer;
metabolite		00low000000
convallatoxin
0
14beta-hydroxy steroid;
19-oxo steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
steroid aldehyde;
steroid lactone		metabolite;
vasodilator agent		00low000000
furostanol i
0
beta-D-glucoside;
cyclic hemiketal;
pentacyclic triterpenoid;
steroid saponin;
trisaccharide derivative		metabolite00low000000
decursinol
0
cyclic ether;
delta-lactone;
organic heterotricyclic compound;
secondary alcohol		analgesic;
antineoplastic agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite		00low000000
abyssinone v
0
4'-hydroxyflavanones;
phenols;
trihydroxyflavanone		metabolite00low000000
davidigenin
0
dihydrochalcones;
polyphenol		anti-allergic agent;
anti-asthmatic agent;
antioxidant;
metabolite		00low000000
farrerol
0
organic molecular entitymetabolite00low000000
naringin
0
(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
neohesperidoside		anti-inflammatory agent;
antineoplastic agent;
metabolite		00low000000
isonaringin
0
(2S)-flavan-4-one;
4'-hydroxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
rutinoside		anti-inflammatory agent;
antioxidant;
metabolite		00low000000
cleomiscosin a
0
aromatic ether;
delta-lactone;
organic heterotricyclic compound;
phenols;
primary alcohol		anti-inflammatory agent;
metabolite		00low000000
vicenin ii
0
C-glycosyl compound;
trihydroxyflavone		metabolite00low000000
eugeniin
0
beta-D-glucoside;
ellagitannin;
gallate ester;
lactone		anti-HSV-1 agent;
antifungal agent;
antineoplastic agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite		00low000000
knipholone
0
aromatic ketone;
dihydroxyanthraquinone;
methoxybenzenes;
methyl ketone;
polyphenol;
resorcinols		antineoplastic agent;
antioxidant;
antiplasmodial drug;
leukotriene antagonist;
metabolite		00low000000
alpha bitter acid
0
aromatic ketone;
cyclic ketone;
diketone;
tertiary alpha-hydroxy ketone;
triol		antibacterial drug;
antioxidant;
cyclooxygenase 2 inhibitor;
metabolite		00low000000
acanthoside b
0
beta-D-glucosidemetabolite00low000000
chlorpromazine n-oxide
0
organochlorine compound;
phenothiazines;
tertiary amine oxide		metabolite00low000000
3-hydroxyaspartic acid, (threo-l)-isomer
0
3-hydroxy-L-aspartic acidmetabolite00low000000
cyclo(l-phe-l-pro)
0
organic molecular entitymetabolite00low000000
pyochelin
0
monocarboxylic acid;
phenols;
thiazolidines		metabolite;
siderophore		00low000000
surfactin c
0
cyclodepsipeptide;
lipopeptide antibiotic;
macrocyclic lactone		antibacterial agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
metabolite;
platelet aggregation inhibitor;
surfactant		00low000000
petunidin-3-glucoside
0
anthocyanin cation;
aromatic ether;
beta-D-glucoside		antioxidant;
metabolite		00low000000
malvidin-3-glucoside
0
anthocyanin cation;
aromatic ether;
beta-D-glucoside		metabolite00low000000
dioncophylline a
0
biaryl;
isoquinoline alkaloid;
isoquinolines;
methoxynaphthalene;
methylnaphthalenes;
naphthalenes		antifungal agent;
antimalarial;
metabolite;
molluscicide		00low000000
dioncophylline c
0
aromatic ether;
biaryl;
isoquinoline alkaloid;
isoquinolines;
methoxynaphthalene;
methylnaphthalenes;
naphthols		antimalarial;
antiplasmodial drug;
metabolite		00low000000
latrunculin a
0
cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin		00low000000
aglucovancomycin b
0
cyclic ether;
heterodetic cyclic peptide;
peptide antibiotic;
peptide zwitterion;
polyphenol		metabolite00low000000
(S)-ATPA
0
isoxazoles;
non-proteinogenic L-alpha-amino acid		metabolite00low000000
epothilone a
0
epothilone;
epoxide		antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator		00low000000
alitretinoin
0
retinoic acidantineoplastic agent;
keratolytic drug;
metabolite;
retinoid X receptor agonist		00low000000
isoleucylvaline
0
dipeptidemetabolite00low000000
afimoxifene
0
phenols;
tertiary amino compound		antineoplastic agent;
estrogen receptor antagonist;
metabolite		00low000000
3-hydroxyhippuric acid
0
N-acylglycine;
phenols		metabolite00low000000
12-deoxyphorbol 13-acetate
0
phorbol estermetabolite00low000000
conidendrin
0
lignanmetabolite00low000000
bevirimat
0
dicarboxylic acid monoester;
monocarboxylic acid;
pentacyclic triterpenoid		HIV-1 maturation inhibitor;
metabolite		00low000000
azaserine
0
carboxylic ester;
diazo compound;
L-serine derivative;
non-proteinogenic L-alpha-amino acid		antifungal agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
glutamine antagonist;
immunosuppressive agent;
metabolite		00low000000
16beta,17-dihydroxy-ent-kaurane-19-oic acid
0
bridged compound;
diol;
ent-kaurane diterpenoid;
hydroxy monocarboxylic acid;
primary alcohol;
tertiary alcohol		anti-HIV agent;
metabolite		00low000000
glycyrin
0
aromatic ether;
coumarins;
hydroxyisoflavans		antibacterial agent;
metabolite;
plant metabolite		00low000000
reynosin
0
organic heterotricyclic compound;
sesquiterpene lactone		metabolite00low000000
moronic acid
0
pentacyclic triterpenoidanti-HIV agent;
anti-HSV-1 agent;
metabolite		00low000000
maltitol
0
alpha-D-glucoside;
glycosyl alditol		laxative;
metabolite;
sweetening agent		00low000000
Phe-Tyr
0
dipeptidemetabolite00low000000
2-acetyl-1-pyrroline
0
acylimine;
methyl ketone;
pyrroline		flavouring agent;
Maillard reaction product;
metabolite		00low000000
methyl indole-3-carboxylate
0
indoles;
methyl ester		metabolite00low000000
camalexin
0
1,3-thiazoles;
indole phytoalexin		metabolite00low000000
komaroviquinone
0
bridged compound;
lactol;
p-quinones;
tetracyclic diterpenoid		metabolite;
trypanocidal drug		00low000000
2-hydroxycinnamic acid
0
2-coumaric acid;
phenols		antioxidant;
metabolite		00low000000
16-epivincamine
0
alkaloidmetabolite00low000000
diethyl fumarate
0
diestermetabolite00low000000
isoliquiritigenin
0
chalconesantineoplastic agent;
biological pigment;
EC 1.14.18.1 (tyrosinase) inhibitor;
GABA modulator;
geroprotector;
metabolite;
NMDA receptor antagonist		00low000000
1-acetyl-beta-carboline
0
harmala alkaloidmetabolite00low000000
propolin c
0
4'-hydroxyflavanones;
tetrahydroxyflavanone		metabolite;
radical scavenger		00low000000
xanthohumol
0
aromatic ether;
chalcones;
polyphenol		anti-HIV-1 agent;
antineoplastic agent;
antiviral agent;
apoptosis inducer;
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor;
metabolite		00low000000
butylidenephthalide
0
2-benzofurans;
gamma-lactone		EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hypoglycemic agent;
metabolite		00low000000
malonyl coenzyme a
0
malonyl-CoAsEC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor;
Escherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
imidazol-1-ylacetic acid
0
imidazolyl carboxylic acidmetabolite00low000000
captax
0
aryl thiol;
benzothiazoles		carcinogenic agent;
metabolite		00low000000
n-acetyltryptophan
0
L-tryptophan derivative;
N-acetyl-L-amino acid		metabolite00low000000
cinnamoylglycine
0
N-acylglycinemetabolite00low000000
n-benzoylalanine
0
N-acyl-L-alanine;
N-benzoylalanine		metabolite00low000000
isoferulic acid
0
ferulic acidsantioxidant;
biomarker;
metabolite		00low000000
oxypeucadanin, (r)-(+)-isomer
0
furanocoumarinmetabolite00low000000
curcumin
0
aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger		00low000000
thiouracil
0
nucleobase analogue;
thiocarbonyl compound		antithyroid drug;
metabolite		00low000000
allylthiourea
0
thioureasmetabolite00low000000
n-glycylalanine
0
dipeptidemetabolite00low000000
caryophyllene oxide
0
epoxidemetabolite00low000000
fumonisin b1
0
diester;
fumonisin;
primary amino compound;
triol		carcinogenic agent;
metabolite		00low000000
olivetolic acid
0
benzoic acids;
monocarboxylic acid;
polyketide;
resorcinols		metabolite00low000000
hirsutine, (16e,20beta)-isomer
0
alkaloidmetabolite00low000000
Ganodermanontriol
0
triterpenoidmetabolite00low000000
dieckol
0
aromatic ether;
oxacycle;
phlorotannin		anticoagulant;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
metabolite;
radical scavenger		00low000000
glycylproline
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
tamoxifen n-oxide
0
aromatic ether;
tertiary amine oxide		anti-estrogen;
metabolite		00low000000
7-deacetylgedunin
0
cyclic terpene ketone;
delta-lactone;
enone;
epoxide;
furans;
limonoid;
pentacyclic triterpenoid		anti-inflammatory agent;
antimalarial;
metabolite;
plant metabolite		00low000000
galactose-6-phosphate
0
D-galactose 6-phosphatemetabolite00low000000
nicotine n-glucuronide
0
iminium betaine;
N-glycosylpyridine		metabolite00low000000
isorhyncophylline
0
indolizinesmetabolite00low000000
cysteinylproline
0
dipeptidemetabolite00low000000
glycyllysine
0
dipeptidemetabolite00low000000
methionyltryptophan
0
dipeptidemetabolite00low000000
ascorbigen
0
indolyl carbohydratemetabolite00low000000
pimeloyl-coenzyme a
0
omega-carboxyacyl-CoAmetabolite00low000000
1-salicylate glucuronide
0
benzoic acids;
beta-D-glucosiduronic acid		metabolite00low000000
isoschaftoside
0
C-glycosyl compound;
trihydroxyflavone		metabolite00low000000
croomine
0
alkaloidmetabolite00low000000
3-hydroxyflavanone
0
3'-hydroxyflavanones;
monohydroxyflavanone		metabolite00low000000
ungeremine
0
organic molecular entitymetabolite00low000000
seryl-proline
0
dipeptidemetabolite00low000000
4-hydroxy-5-methyl-3(2h)-furanone
0
cyclic ketone;
enol;
furans		metabolite00low000000
annomontine
0
alkaloid;
aminopyrimidine;
beta-carbolines		antiparasitic agent;
metabolite		00low000000
8-hydroxymanzamine a
0
alkaloid;
beta-carbolines;
isoquinolines		anti-HSV-2 agent;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
metabolite		00low000000
ginkgetin
0
biflavonoid;
hydroxyflavone;
methoxyflavone;
ring assembly		anti-HSV-1 agent;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite		00low000000
calceolarioside b
0
hydroxycinnamic acidmetabolite00low000000
eupatilin
0
dihydroxyflavone;
trimethoxyflavone		anti-inflammatory agent;
anti-ulcer drug;
antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
metabolite		00low000000
quercetin 3-o-glucuronide
0
beta-D-glucosiduronic acid;
quercetin O-glycoside		antidepressant;
antioxidant;
metabolite		00low000000
australifungin
0
carbobicyclic compound;
enol;
enone;
secondary alcohol		antifungal agent;
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor;
HIV-1 integrase inhibitor;
metabolite		00low000000
catechin gallate
0
flavans;
gallate ester;
polyphenol		metabolite00low000000
sterigmatocystin
0
sterigmatocystinsmetabolite00low000000
3,7-dimethoxy-5,3',4'-trihydroxyflavone
0
dimethoxyflavone;
trihydroxyflavone		EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite		00low000000
apigenin
0
trihydroxyflavoneantineoplastic agent;
metabolite		00low000000
7,3'-dihydroxy-4'-methoxyisoflavone
0
4'-methoxyisoflavones;
7-hydroxyisoflavones		antioxidant;
metabolite		00low000000
calcitriol
0
D3 vitamins;
hydroxycalciol;
triol		antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical		00low000000
vomifoliol
0
(6S)-vomifoliolmetabolite;
phytotoxin		00low000000
feruloyltyramine
0
tyraminesmetabolite00low000000
luteolin-7-glucuronide
0
glycosyloxyflavone;
luteolin O-glucuronoside;
monosaccharide derivative;
trihydroxyflavone		metabolite00low000000
chrysoeriol
0
monomethoxyflavone;
trihydroxyflavone		antineoplastic agent;
antioxidant;
metabolite		00low000000
quercetin 3-o-methyl ether
0
monomethoxyflavone;
tetrahydroxyflavone		antimicrobial agent;
metabolite		00low000000
dexmedetomidine
0
trihydroxyflavone;
trimethoxyflavone		antineoplastic agent;
metabolite		00low000000
apigetrin
0
beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		antibacterial agent;
metabolite;
non-steroidal anti-inflammatory drug		00low000000
rutin
0
disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone		antioxidant;
metabolite		00low000000
6-ketoprostaglandin e1
0
prostaglandins Emetabolite;
platelet aggregation inhibitor		00low000000
lipoxin a4
0
hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid		human metabolite;
metabolite		00low000000
harmine
0
harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite		00low000000
naringenin chalcone
0
chalcones;
polyphenol		anti-allergic agent;
anti-inflammatory agent;
metabolite		00low000000
cornexistin
0
cyclic dicarboxylic anhydride;
organic heterobicyclic compound;
secondary alpha-hydroxy ketone		herbicide;
metabolite		00low000000
isobavachalcone
0
chalcones;
polyphenol		antibacterial agent;
metabolite;
platelet aggregation inhibitor		00low000000
daphnoretin
0
aromatic ether;
hydroxycoumarin		antineoplastic agent;
antiviral agent;
metabolite		00low000000
Rhynchophylline
0
indolizinesmetabolite00low000000
esculin
0
beta-D-glucoside;
hydroxycoumarin		antioxidant;
metabolite		00low000000
mammeisin
0
neoflavonoidmetabolite00low000000
ostruthin
0
terpene lactonemetabolite00low000000
costunolide
0
germacranolide;
heterobicyclic compound		anthelminthic drug;
antiinfective agent;
antineoplastic agent;
antiparasitic agent;
antiviral drug;
metabolite		00low000000
caryophyllene
0
beta-caryophyllenefragrance;
insect attractant;
metabolite;
non-steroidal anti-inflammatory drug		00low000000
phaseic acid
0
alpha,beta-unsaturated monocarboxylic acid;
apo carotenoid sesquiterpenoid		metabolite00low000000
agathisflavone
0
biaryl;
biflavonoid;
hydroxyflavone		antineoplastic agent;
antiviral agent;
hepatoprotective agent;
metabolite		00low000000
cupressuflavone
0
biflavonoid;
hydroxyflavone;
ring assembly		EC 3.4.21.37 (leukocyte elastase) inhibitor;
metabolite;
radical scavenger		00low000000
fisetin
0
3'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite		00low000000
genkwanin
0
dihydroxyflavone;
monomethoxyflavone		metabolite00low000000
bellidifolin
0
polyphenol;
xanthones		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
hypoglycemic agent;
metabolite		00low000000
demethylbellidifolin
0
tetrol;
xanthones		antioxidant;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite;
mutagen;
radical scavenger		00low000000
hinokiflavone
0
aromatic ether;
biflavonoid;
hydroxyflavone		antineoplastic agent;
metabolite;
neuroprotective agent		00low000000
euxanthone
0
phenols;
xanthones		metabolite;
plant metabolite		00low000000
3-methylquercetin
0
7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone		anticoagulant;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite		00low000000
norswertianolin
0
beta-D-glucoside;
xanthones		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite		00low000000
swerchirin
0
aromatic ether;
phenols;
xanthones		hypoglycemic agent;
metabolite		00low000000
isoscutellarein
0
tetrahydroxyflavonemetabolite00low000000
kaempferide
0
7-hydroxyflavonol;
monomethoxyflavone;
trihydroxyflavone		antihypertensive agent;
metabolite		00low000000
morin
0
7-hydroxyflavonol;
pentahydroxyflavone		angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent		00low000000
norwogonin
0
trihydroxyflavoneantioxidant;
metabolite		00low000000
orientin
0
3'-hydroxyflavonoid;
C-glycosyl compound;
tetrahydroxyflavone		antioxidant;
metabolite		00low000000
patuletin
0
flavonols;
monomethoxyflavone;
pentahydroxyflavone		analgesic;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
lipoxygenase inhibitor;
metabolite		00low000000
rhamnetin
0
monomethoxyflavone;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
metabolite		00low000000
robustaflavone
0
biflavonoid;
hydroxyflavone;
ring assembly		anti-HBV agent;
antineoplastic agent;
antioxidant;
metabolite		00low000000
scutellarein
0
tetrahydroxyflavonemetabolite00low000000
tamarixetin
0
7-hydroxyflavonol;
monomethoxyflavone;
tetrahydroxyflavone		antioxidant;
metabolite		00low000000
tricetin
0
pentahydroxyflavoneantineoplastic agent;
metabolite		00low000000
tricin
0
3'-methoxyflavones;
dimethoxyflavone;
trihydroxyflavone		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite		00low000000
astringin
0
beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		antineoplastic agent;
antioxidant;
metabolite		00low000000
polydatin
0
beta-D-glucoside;
monosaccharide derivative;
polyphenol;
stilbenoid		anti-arrhythmia drug;
antioxidant;
geroprotector;
hepatoprotective agent;
metabolite;
nephroprotective agent;
potassium channel modulator		00low000000
epsilon-viniferin
0
1-benzofurans;
polyphenol;
stilbenoid		metabolite00low000000
irilone
0
hydroxyisoflavone;
organic heterotricyclic compound;
oxacycle		antineoplastic agent;
immunomodulator;
metabolite		00low000000
caffeic acid phenethyl ester
0
alkyl caffeate esteranti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
antioxidant;
antiviral agent;
immunomodulator;
metabolite;
neuroprotective agent		00low000000
licoisoflavone a
0
7-hydroxyisoflavonesmetabolite00low000000
prunetin
0
7-methoxyisoflavones;
hydroxyisoflavone		anti-inflammatory agent;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite		00low000000
wedelolactone
0
aromatic ether;
coumestans;
delta-lactone;
polyphenol		antineoplastic agent;
apoptosis inducer;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
hepatoprotective agent;
metabolite		00low000000
rottlerin
0
aromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone		anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite		00low000000
syringetin
0
3',5'-dimethoxyflavone;
3'-methoxyflavones;
7-hydroxyflavonol;
dimethoxyflavone;
tetrahydroxyflavone		metabolite;
platelet aggregation inhibitor		00low000000
10-deoxymethynolide
0
macrolidemetabolite00low000000
4',7-dihydroxyflavone
0
dihydroxyflavonemetabolite00low000000
rhoifolin
0
dihydroxyflavone;
glycosyloxyflavone;
neohesperidoside		metabolite00low000000
veronicastroside
0
disaccharide derivative;
glycosyloxyflavone;
neohesperidoside;
trihydroxyflavone		antibacterial agent;
metabolite		00low000000
quercimeritrin
0
beta-D-glucoside;
flavonols;
monosaccharide derivative;
quercetin O-glucoside;
tetrahydroxyflavone		antioxidant;
metabolite		00low000000
josamycin
0
acetate ester;
aldehyde;
disaccharide derivative;
glycoside;
macrolide antibiotic;
tertiary alcohol;
tertiary amino compound		antibacterial drug;
metabolite		00low000000
n,n-dimethylsphingenine
0
aminodiol;
sphingoid;
tertiary amino compound		EC 2.7.1.91 (sphingosine kinase) inhibitor;
metabolite		00low000000
4-hydroxyestradiol
0
4-hydroxy steroidmetabolite00low000000
9-hydroxy-10,12-octadecadienoic acid
0
HODE;
octadecadienoic acid		human metabolite;
metabolite;
mouse metabolite;
plant metabolite		00low000000
9-oxo-10,12-octadecadienoic acid
0
enone;
oxooctadecadienoic acid		metabolite00low000000
13-oxo-9,11-octadecadienoic acid
0
13-oxo-9,11-octadecadienoic acid;
oxo fatty acid		metabolite00low000000
13,14-dihydro-15-ketoprostaglandin d2
0
prostaglandins Dmetabolite00low000000
15-keto-13,14-dihydroprostaglandin f2alpha
0
ketone;
prostaglandins Falpha		metabolite00low000000
2,3-dinor-6-ketoprostaglandin f1alpha
0
4-oxo monocarboxylic acid;
prostanoid;
secondary alcohol		metabolite00low000000
ergosta-7,22-dien-3-ol, (3beta,5alpha,6alpha,22e)-isomer
0
3beta-sterolanti-HSV-1 agent;
antifungal agent;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
metabolite		00low000000
calcifediol
0
D3 vitamins;
diol;
hydroxycalciol		bone density conservation agent;
human metabolite;
metabolite;
mouse metabolite;
nutraceutical		00low000000
cyclosporine
0
homodetic cyclic peptideanti-asthmatic drug;
anticoronaviral agent;
antifungal agent;
antirheumatic drug;
carcinogenic agent;
dermatologic drug;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
geroprotector;
immunosuppressive agent;
metabolite		00low000000
oleyl alcohol
0
fatty alcohol 18:1;
long-chain primary fatty alcohol		metabolite;
nonionic surfactant		00low000000
fortimicin a
0
amino cyclitol glycoside;
aminoglycoside antibiotic;
diol;
monocarboxylic acid amide;
primary amino compound		antibacterial agent;
metabolite		00low000000
3',4',7-trihydroxyisoflavone
0
7-hydroxyisoflavonesantineoplastic agent;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite		00low000000
6,7,4'-trihydroxyisoflavone
0
7-hydroxyisoflavonesanti-inflammatory agent;
antimutagen;
EC 1.14.18.1 (tyrosinase) inhibitor;
metabolite;
PPARalpha agonist;
PPARgamma agonist		00low000000
15-deoxy-delta(12,14)-prostaglandin j2
0
prostaglandins Jelectrophilic reagent;
insulin-sensitizing drug;
metabolite		00low000000
cytochalasin b
0
cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor		00low000000
ciguatoxins
0
ciguatoxinmetabolite00low000000
12-hydroxy-5,8,10-heptadecatrienoic acid
0
hydroxy polyunsaturated fatty acid;
long-chain fatty acid;
trienoic fatty acid		metabolite00low000000
bisdemethoxycurcumin
0
beta-diketone;
diarylheptanoid;
enone;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
metabolite		00low000000
clausine e
0
carbazolesmetabolite00low000000
ethyl caffeate
0
alkyl caffeate ester;
ethyl ester;
hydroxycinnamic acid		anti-inflammatory agent;
antineoplastic agent;
metabolite		00low000000
heptaphylline
0
carbazolesmetabolite00low000000
pellitorine
0
fatty amidemetabolite00low000000
andrographolide
0
carbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol		anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite		00low000000
isorhamnetin-3-o-galactoside
0
beta-D-galactoside;
glycosyloxyflavone;
monomethoxyflavone;
monosaccharide derivative;
trihydroxyflavone		metabolite00low000000
isorhamnetin 3-o-glucoside
0
beta-D-glucoside;
glycosyloxyflavone;
monomethoxyflavone;
monosaccharide derivative;
trihydroxyflavone		metabolite00low000000
kaempferol-3-o-rutinoside
0
disaccharide derivative;
kaempferol O-glucoside;
rutinoside;
trihydroxyflavone		metabolite;
plant metabolite;
radical scavenger		00low000000
ligustilide
0
butenolidemetabolite00low000000
7,4'-dihydroxy-3'-methoxyisoflavone
0
7-hydroxyisoflavones;
methoxyisoflavone		antiplasmodial drug;
metabolite		00low000000
sappanchalcone
0
catechols;
chalcones;
monomethoxybenzene		anti-allergic agent;
anti-inflammatory agent;
antioxidant;
metabolite		00low000000
methyl brevifolincarboxylate
0
cyclic ketone;
delta-lactone;
organic heterotricyclic compound;
phenols		EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite;
platelet aggregation inhibitor;
radical scavenger;
vasodilator agent		00low000000
3-deoxysappanchalcone
0
chalcones;
monomethoxybenzene;
phenols		metabolite00low000000
nostocarboline
0
alkaloid;
beta-carbolines;
organic cation;
organochlorine compound		antimalarial;
EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite		00low000000
ergosterol-5,8-peroxide
0
3beta-sterol;
ergostanoid;
organic peroxide;
phytosterols		antimycobacterial drug;
antineoplastic agent;
metabolite;
trypanocidal drug		00low000000
3-(4-hydroxy-3-methoxyphenyl)-n-(2-(4-hydroxy-3-methoxyphenyl)ethyl)-2-propenamide
0
hydroxycinnamic acidmetabolite00low000000
macluraxanthone b
0
phenols;
xanthones		anti-HIV agent;
antineoplastic agent;
metabolite		00low000000
flavokawain b
0
chalcones;
dimethoxybenzene;
phenols		anti-inflammatory agent;
antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
metabolite		00low000000
alternariol
0
benzochromenone;
phenols		EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite;
mycotoxin		00low000000
cis-3-hexenyl acetate
0
acetate ester;
olefinic compound		metabolite00low000000
pipercallosidine
0
alkaloid;
benzodioxoles;
enamide;
secondary carboxamide		apoptosis inducer;
metabolite;
plant metabolite		00low000000
n-(4-hydroxy-beta-phenethyl)-4-hydroxycinnamide
0
hydroxycinnamic acidmetabolite00low000000
7-hydroxyisoflavone
0
7-hydroxyisoflavonesEC 1.14.14.14 (aromatase) inhibitor;
metabolite		00low000000
flazin
0
harmala alkaloidmetabolite00low000000
11-hydroxynoracronycine
0
acridinesmetabolite00low000000
jaceosidin
0
dimethoxyflavone;
trihydroxyflavone		anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
metabolite		00low000000
5,7,3'-trihydroxy-3,4'-dimethoxyflavone
0
dimethoxyflavone;
trihydroxyflavone		antineoplastic agent;
metabolite		00low000000
salutaridine
0
morphinane alkaloidanti-HBV agent;
metabolite		00low000000
cytochalasin e
0
cytochalasan alkaloidmetabolite00low000000
artocarpin lectin
0
monomethoxyflavone;
trihydroxyflavone		antineoplastic agent;
metabolite		00low000000
fumarates
0
butenedioate;
C4-dicarboxylate		human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite		00low000000
bleomycin
0
bleomycinantineoplastic agent;
metabolite		00low000000
1,7-dihydroxy-4-methoxyxanthone
0
aromatic ether;
phenols;
xanthones		metabolite;
plant metabolite		00low000000
demethoxycurcumin
0
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antineoplastic agent;
metabolite		00low000000
bergamottin
0
furanocoumarinmetabolite00low000000
alanyl-alanyl-alanine
0
tripeptidemetabolite00low000000
24-ethyl-4-cholesten-3-one
0
C29-steroid;
steroid		metabolite00low000000
myricetin 3-o-glucuronide
0
monosaccharide derivative;
myricetin O-glucuronide;
pentahydroxyflavone		metabolite00low000000
phenylalanylalanine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
alpinumisoflavone
0
isoflavanonesmetabolite00low000000
alpha-aspartylalanine
0
dipeptidemetabolite00low000000
alanyltyrosine
0
dipeptidemetabolite00low000000
arglabin
0
epoxide;
gamma-lactone;
organic heterotetracyclic compound;
sesquiterpene lactone		antineoplastic agent;
metabolite		00low000000
ap 10
0
diterpene lactonemetabolite00low000000
quercetin 7-rhamnoside
0
alpha-L-rhamnoside;
flavonols;
monosaccharide derivative;
quercetin O-glycoside;
tetrahydroxyflavone		metabolite00low000000
albonoursin
0
2,5-diketopiperazinesmetabolite00low000000
oroidin
0
pyrroles;
secondary carboxamide		metabolite00low000000
monorden
0
cyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols		antifungal agent;
metabolite;
tyrosine kinase inhibitor		00low000000
apratoxin a
0
1,3-thiazoles;
apratoxin		antineoplastic agent;
metabolite		00low000000
(-)-catechin-3-O-gallate
0
flavans;
gallate ester;
polyphenol		metabolite00low000000
aspartyllysine
0
dipeptidemetabolite00low000000
arginyllysine
0
dipeptidemetabolite00low000000
hygromycin a
0
hydroxycinnamic acidmetabolite00low000000
latrunculin b
0
cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin		00low000000
falcarindiol
0
organic molecular entitymetabolite00low000000
dehydroergosterol
0
3beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
ergostanoid;
phytosterols		biomarker;
metabolite		00low000000
n-oleoylglycine
0
fatty amide;
N-acylglycine 18:1		metabolite00low000000
rhizoxin
0
1,3-oxazoles;
epoxide;
macrolide antibiotic		antimitotic;
antineoplastic agent;
metabolite		00low000000
manoalide
0
butenolide;
lactol;
sesterterpenoid		EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite		00low000000
concanamycin a
0
carbamate ester;
concanamycin		antifungal agent;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
metabolite		00low000000
n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid
0
enoate ester;
methyl ester;
monocarboxylic acid amide		metabolite00low000000
thunberginol f
0
catechols;
gamma-lactone;
isobenzofuranone		metabolite;
plant metabolite		00low000000
pyracrenic acid
0
triterpenoidmetabolite00low000000
eicosa-11,14-dienoic acid, (z,z)-isomer
0
icosadienoic acidmetabolite00low000000
yuanhuadine
0
diterpenoidmetabolite00low000000
tiglylglycine
0
N-acylglycinemetabolite00low000000
rhodiocyanoside a
0
aliphatic nitrile;
beta-D-glucoside;
cyanogenic glycoside;
monosaccharide derivative		anti-allergic agent;
metabolite		00low000000
(2E,4E)-N-isobutyl-2,4-dodecadienamide
0
fatty amidemetabolite00low000000
mycothiazole
0
thiazolesmetabolite00low000000
13-oxo-9,11-octadecadienoic acid
0
13-oxo-9,11-octadecadienoic acidmetabolite;
mouse metabolite		00low000000
linderalactone
0
butenolidemetabolite00low000000
pros-methylimidazoleacetic acid
0
imidazolyl carboxylic acidmetabolite00low000000
cellobionic acid
0
carbohydrate acid;
disaccharide		metabolite00low000000
pseudopteroxazole
0
tetralinsmetabolite00low000000
sophoraflavanone a
0
(2S)-flavan-4-one;
4'-hydroxyflavanones;
trihydroxyflavanone		antibacterial agent;
antineoplastic agent;
metabolite		00low000000
stigmasterol 3-o-beta-d-glucopyranoside
0
beta-D-glucoside;
monosaccharide derivative;
phytosterols;
steroid saponin		metabolite00low000000
17-hydroxyjolkinolide b
0
diterpene lactonemetabolite00low000000
sq-23377
0
cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid		calcium ionophore;
metabolite		00low000000
corosolic acid
0
triterpenoidmetabolite00low000000
cyclo(prolyl-valyl)
0
piperazinonemetabolite00low000000
phenylalanylglycine
0
dipeptidemetabolite00low000000
leucyl-phenylalanine
0
dipeptidemetabolite00low000000
glutamylalanine
0
dipeptidemetabolite00low000000
glutaminyl-glycine
0
dipeptidemetabolite00low000000
methionylglycine
0
dipeptidemetabolite00low000000
valylleucine
0
dipeptidemetabolite00low000000
phenylalanyl-valine
0
dipeptidemetabolite00low000000
cyclo(glycyltryptophyl)
0
indolesmetabolite00low000000
alanylglycine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
valyltyrosine
0
dipeptidemetabolite00low000000
alpha-glutamyltryptophan
0
dipeptidemetabolite00low000000
lysylglutamic acid
0
dipeptidemetabolite00low000000
methionylglutamic acid
0
dipeptidemetabolite00low000000
seryl-histidine
0
dipeptidemetabolite00low000000
arginyl-glutamine
0
dipeptidemetabolite00low000000
phenylalanylproline
0
dipeptidemetabolite00low000000
lysylglycine
0
dipeptidemetabolite00low000000
glycylhistidine
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
kopsinine
0
indole alkaloidmetabolite00low000000
cyclo(leucyl-phenylalanyl)
0
2,5-diketopiperazinesmetabolite00low000000
prolylisoleucine
0
dipeptidemetabolite00low000000
phenylalanyl-valine
0
dipeptidemetabolite00low000000
isoleucyl-tyrosine
0
dipeptidemetabolite00low000000
prolyl-serine
0
dipeptidemetabolite00low000000
grayanotoxin i
0
acetate ester;
pentol;
secondary alcohol;
tertiary alcohol;
tetracyclic diterpenoid		antihypertensive agent;
metabolite;
neuromuscular agent;
phytotoxin		00low000000
19-norandrosterone
0
17-oxo steroidmetabolite00low000000
s-allylcysteine
0
L-alpha-amino acid zwitterion;
S-hydrocarbyl-L-cysteine		antineoplastic agent;
metabolite		00low000000
oleandrigenin
0
14beta-hydroxy steroid;
3beta-hydroxy steroid;
steroid ester		EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite		00low000000
valyl-prolyl-proline
0
tripeptidemetabolite00low000000
prolylvaline
0
dipeptidemetabolite00low000000
palbinone
0
16-oxo steroidmetabolite00low000000
pseurotin
0
azaspiro compound;
lactam;
oxaspiro compound		metabolite00low000000
gambogic acid
0
pyranoxanthonesmetabolite00low000000
xenovulene a
0
cyclic ether;
enone;
organic heterotetracyclic compound;
sesquiterpenoid		GABA antagonist;
metabolite		00low000000
fr 148083
0
aromatic ether;
macrolide;
phenols;
secondary alcohol;
secondary alpha-hydroxy ketone		antibacterial agent;
antineoplastic agent;
metabolite;
NF-kappaB inhibitor		00low000000
LL-Z1640-1
0
macrolide;
resorcinols		metabolite00low000000
9-methoxycanthin-6-one
0
aromatic ether;
indole alkaloid;
organic heterotetracyclic compound		antineoplastic agent;
antiplasmodial drug;
metabolite		00low000000
n-acetylcarnosine
0
dipeptidemetabolite00low000000
cholest-5-en-3-one
0
3-oxo-Delta(5)-steroid;
cholestanoid		metabolite00low000000
kaempferol 3-O-beta-L-glucopyranoside
0
beta-L-glucoside;
flavonols;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone		metabolite00low000000
rubraxanthone
0
aromatic ether;
polyphenol;
xanthones		antibacterial agent;
antineoplastic agent;
metabolite		00low000000
ubiquinol
0
polyprenylhydroquinone;
ubiquinol		biomarker;
metabolite		00low000000
landomycin a
0
oligosaccharidemetabolite00low000000
ancistroealaine a
0
aromatic ether;
biaryl;
isoquinoline alkaloid;
isoquinolines;
methoxynaphthalene;
methylnaphthalenes		antileishmanial agent;
antiplasmodial drug;
metabolite;
trypanocidal drug		00low000000
cerberin
0
acetate ester;
cardenolide glycoside;
monosaccharide derivative		antineoplastic agent;
metabolite		00low000000
actein
0
triterpenoidmetabolite00low000000
araloside a
0
triterpenoid saponinmetabolite00low000000
ageladine a
0
alkaloid;
aromatic amine;
imidazopyridine;
organobromine compound;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor;
metabolite		00low000000
corynoxine b
0
indolizinesmetabolite00low000000
kaempferol 7-o-glucoside
0
beta-D-glucoside;
flavonols;
kaempferol O-glucoside;
monosaccharide derivative;
trihydroxyflavone		metabolite;
plant metabolite;
radical scavenger		00low000000
delphinidin 3-sambubioside
0
anthocyanidin 3-O-beta-D-sambubiosideapoptosis inducer;
metabolite		00low000000
nodosin
0
delta-lactonemetabolite00low000000
protylonolide
0
diol;
enone;
macrolide		metabolite00low000000
arisugacin
0
aromatic ether;
delta-lactone;
enone;
organic heterotetracyclic compound;
tertiary alcohol		antimicrobial agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite;
Penicillium metabolite		00low000000
nymphaeol c
0
4'-hydroxyflavanones;
tetrahydroxyflavanone		metabolite;
radical scavenger		00low000000
thonningianin a
0
tanninmetabolite00low000000
cephalostatin i
0
oxo steroidmetabolite00low000000
papyriflavonol a
0
3'-hydroxyflavonoid;
flavonols;
pentahydroxyflavone		EC 1.14.18.1 (tyrosinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
metabolite		00low000000
lactonamycin
0
gamma-lactone;
organic heterohexacyclic compound;
phenols;
trideoxyhexose derivative		antibacterial agent;
antimicrobial agent;
metabolite		00low000000
myrsinoic acid b
0
1-benzofurans;
monocarboxylic acid		anti-inflammatory agent;
EC 4.4.1.11 (methionine gamma-lyase) inhibitor;
metabolite		00low000000
betulone
0
triterpenoidmetabolite00low000000
eckstolonol
0
organic heteropentacyclic compound;
oxacycle;
phlorotannin		metabolite;
radical scavenger		00low000000
manassantin b
0
benzodioxoles;
dimethoxybenzene;
lignan;
oxolanes;
secondary alcohol		antineoplastic agent;
metabolite		00low000000
gitaloxin
0
cardenolide glycosidemetabolite00low000000
paeonilide
0
benzoate estermetabolite00low000000
dihydroxanthohumol
0
aromatic ether;
dihydrochalcones;
polyphenol		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite		00low000000
corynoxine
0
indolizinesmetabolite00low000000
7-phloroeckol
0
aromatic ether;
phlorotannin		antioxidant;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
metabolite		00low000000
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranoside
0
beta-D-glucoside;
dimethoxybenzene;
lignan;
monosaccharide derivative;
polyphenol;
primary alcohol;
tetralins		antibacterial agent;
antifungal agent;
metabolite		00low000000
Sphaeropsidin C
0
tricyclic diterpenoidmetabolite00low000000
kelampayoside a
0
glycosidemetabolite00low000000
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranoside
0
aromatic ether;
benzyl alcohols;
beta-D-glucoside;
monosaccharide derivative;
primary alcohol		antineoplastic agent;
metabolite		00low000000
2,3-dihydro-3beta-methoxy withaferin A
0
27-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
epoxy steroid;
ergostanoid;
primary alcohol;
secondary alcohol;
withanolide		metabolite;
plant metabolite		00low000000
nigranoic acid
0
dicarboxylic acid;
tetracyclic triterpenoid		antineoplastic agent;
HIV-1 reverse transcriptase inhibitor;
metabolite		00low000000
esculeoside a
0
azaspiro compound;
oxaspiro compound;
saponin;
steroid alkaloid;
steroid saponin		antineoplastic agent;
metabolite		00low000000
aerothionin
0
isoxazolesmetabolite00low000000
artemisic acid
0
carbobicyclic compound;
monocarboxylic acid;
octahydronaphthalenes;
sesquiterpenoid		metabolite00low000000
26-deoxyactein
0
triterpenoidmetabolite00low000000
5-formylcytosine
0
aminopyrimidine;
heteroarenecarbaldehyde;
nucleobase analogue;
pyrimidone		metabolite00low000000
migrastatin
0
ether;
macrolide antibiotic;
piperidones;
secondary alcohol		antineoplastic agent;
metabolite		00low000000
Lyngbic acid
0
long-chain fatty acidmetabolite00low000000
2,3,6,8-tetrahydroxy-1-(3-methylbut-2-enyl)-5-(2-methylbut-3-en-2-yl)-9h-xanthen-9-one
0
polyphenol;
xanthones		anti-inflammatory agent;
antineoplastic agent;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
metabolite		00low000000
bielschowskysin
0
acetate ester;
cyclic acetal;
diterpenoid;
gamma-lactone;
organic heterohexacyclic compound		antimalarial;
antineoplastic agent;
metabolite		00low000000
procyanidin b1
0
biflavonoid;
hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
EC 3.4.21.5 (thrombin) inhibitor;
metabolite		00low000000
cyclo(tyrosyl-tyrosyl)
0
cyclo(tyrosyl-tyrosyl)metabolite00low000000
spiculoic acid a
0
carbobicyclic compound;
cyclic ketone;
oxo monocarboxylic acid;
styrenes		antineoplastic agent;
metabolite		00low000000
myrocin a
0
tertiary alcoholmetabolite00low000000
3'-o-methylepicatechin
0
catechinmetabolite00low000000
episilvestrol
0
dioxanes;
ether;
methyl ester;
organic heterotricyclic compound		antineoplastic agent;
metabolite		00low000000
protopanaxatriol
0
12beta-hydroxy steroid;
3beta-hydroxy-4,4-dimethylsteroid;
3beta-hydroxy steroid;
6alpha-hydroxy steroid;
sapogenin;
tetracyclic triterpenoid		metabolite00low000000
laurinterol
0
organobromine compound;
phenols;
sesquiterpenoid		antibacterial agent;
apoptosis inducer;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
metabolite		00low000000
Pseudopterosin G-J aglycone
0
diterpenoidmetabolite00low000000
ceratamine a
0
alkaloid;
aromatic ether;
cyclic ketone;
organic heterobicyclic compound;
organobromine compound;
secondary amino compound;
tertiary amine		antimitotic;
metabolite		00low000000
liphagal
0
aldehyde;
cyclic ether;
meroterpenoid;
organic heterotetracyclic compound;
polyphenol		EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
metabolite		00low000000
pulsatilla saponin d
0
triterpenoidmetabolite00low000000
diversonol
0
phenols;
tertiary alcohol		antibacterial agent;
metabolite		00low000000
neotuberostemonine
0
alkaloidmetabolite00low000000
drymaritin
0
enol ether;
enone;
indole alkaloid;
organic heterotetracyclic compound		anti-HIV agent;
metabolite		00low000000
lyoniresinol
0
dimethoxybenzene;
lignan;
polyphenol;
primary alcohol;
tetralins		antineoplastic agent;
metabolite		00low000000
silvestrol
0
dioxanes;
ether;
methyl ester;
organic heterotricyclic compound		antineoplastic agent;
metabolite		00low000000
ginsenoside ro
0
triterpenoid saponinmetabolite00low000000
diosgenin glucoside
0
hexacyclic triterpenoid;
monosaccharide derivative;
spiroketal;
sterol 3-beta-D-glucoside		metabolite00low000000
pyripyropene a
0
organic heterotetracyclic compound;
sesquiterpenoid		acyl-CoA:cholesterol acyltransferase 2 inhibitor;
metabolite		00low000000
3-epioleanolic acid
0
triterpenoidmetabolite00low000000
leucylproline
0
dipeptide zwitterion;
dipeptide		metabolite00low000000
R-(-)-actinodaphnine
0
aporphine alkaloidmetabolite00low000000
cytotrienin a
0
cyclopropanecarboxylate ester;
ether;
hydroquinones;
lactam;
macrocycle;
secondary alcohol		antibacterial agent;
antimicrobial agent;
antineoplastic agent;
apoptosis inducer;
metabolite		00low000000
methylamphotericin b
0
macrolide;
methyl ester;
monosaccharide derivative		antifungal agent;
antiinfective agent;
metabolite		00low000000
2'-methoxykurarinone
0
4'-hydroxyflavanones;
dihydroxyflavanone;
dimethoxyflavanone		antineoplastic agent;
metabolite		00low000000
verproside
0
glycosidemetabolite00low000000
verminoside
0
hydroxycinnamic acidmetabolite00low000000
minecoside
0
hydroxycinnamic acidmetabolite00low000000
(R)-(+)-6',7'-dihydroxybergamottin
0
furanocoumarinmetabolite00low000000
lapidilectine b
0
indolyl carboxylic acidmetabolite00low000000
batzelladine a
0
alkaloid;
carboxylic ester;
guanidines;
organic heterotricyclic compound;
pyrrolopyrimidine;
triazaacenaphthylene		anti-HIV-1 agent;
metabolite		00low000000
alloin
0
anthracenes;
C-glycosyl compound;
cyclic ketone;
phenols		laxative;
metabolite		00low000000
longipinene
0
alpha-longipinenemetabolite00low000000
parkeol
0
3beta-hydroxy-4,4-dimethylsteroid;
3beta-sterol;
tetracyclic triterpenoid		metabolite00low000000
rutundic acid
0
triterpenoidmetabolite00low000000
a-factor (streptomyces)
0
butan-4-olide;
primary alcohol		metabolite00low000000
taraxasteryl acetate
0
triterpenoidmetabolite00low000000
chikusetsu saponin iva
0
triterpenoid saponinmetabolite00low000000
xestoaminol c
0
amino alcohol;
sphingoid		metabolite00low000000
malyngamide A
0
dicarboximidemetabolite00low000000
simalikalactone D
0
cyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
triol		antimalarial;
antineoplastic agent;
antiviral agent;
metabolite		00low000000
friedelane
0
triterpenemetabolite00low000000
shamixanthone
0
cyclic ketone;
phenols;
pyranoxanthene		metabolite00low000000
17,18-epoxy-5,8,11,14-eicosatetraenoic acid
0
EpETEmetabolite00low000000
chaetominine
0
indole alkaloid;
lactam;
organic heterotetracyclic compound;
quinazolines		metabolite00low000000
schweinfurthin g
0
cyclic ether;
organic heterotricyclic compound;
resorcinols;
stilbenoid		antineoplastic agent;
metabolite		00low000000
salmon calcitonin
0
heterodetic cyclic peptide;
peptide hormone;
polypeptide		bone density conservation agent;
metabolite		00low000000
complestatin
0
cyclic ether;
heterodetic cyclic peptide;
indoles;
organic heterobicyclic compound;
organochlorine compound;
peptide antibiotic;
polyphenol		anti-HIV-1 agent;
antimicrobial agent;
HIV-1 integrase inhibitor;
metabolite		00low000000
neuroprotectin a
0
cyclic ether;
heterodetic cyclic peptide;
indoles;
organochlorine compound;
polyphenol		HIV-1 integrase inhibitor;
metabolite		00low000000
alx-0600
0
polypeptideantioxidant;
glucagon-like peptide-2 receptor agonist;
metabolite;
protective agent		00low000000
schweinfurthin f
0
cyclic ether;
organic heterotricyclic compound;
resorcinols;
stilbenoid		metabolite00low000000
antrocamphin a
0
methoxybenzenesanti-inflammatory agent;
metabolite		00low000000
respirantin
0
benzamides;
cyclodepsipeptide;
formamides;
phenols		antimicrobial agent;
antineoplastic agent;
metabolite		00low000000
streptobiosamine
0
amino disaccharidemetabolite00low000000
interiotherin b
0
aromatic ether;
fatty acid ester;
lignan;
organic heteropentacyclic compound;
oxacycle		anti-HIV agent;
metabolite		00low000000
succinyladenosine
0
adenosines;
amino dicarboxylic acid;
L-aspartic acid derivative		metabolite00low000000
6-tuliposide a
0
6-O-acyl-D-glucose;
homoallylic alcohol		allergen;
metabolite		00low000000
glycochenodeoxycholate-3-sulfate
0
7alpha-hydroxy steroid;
bile acid glycine conjugate;
steroid sulfate		metabolite00low000000
wewakazole
0
cyclic peptidemetabolite00low000000
spongia-13(16),14-dien-19-oic acid
0
cyclic ether;
monocarboxylic acid;
tetracyclic diterpenoid		androgen antagonist;
metabolite		00low000000
Icariside E4
0
benzofuransmetabolite00low000000
lucidenic acid n
0
cyclic terpene ketone;
dioxo monocarboxylic acid;
secondary alcohol;
tetracyclic triterpenoid		antineoplastic agent;
EC 3.1.1.8 (cholinesterase) inhibitor;
metabolite		00low000000
dihydroagarofuran
0
bridged compound;
cyclic ether;
eudesmane sesquiterpenoid;
organic heterotricyclic compound		metabolite00low000000
23-epi-26-deoxyactein
0
triterpenoidmetabolite00low000000
23-hydroxybetulinic acid
0
triterpenoidmetabolite00low000000
(1S,3aR,4S,6S,6aS,9aS,9bS)-9a-isocyano-6-(2-isocyano-2-methylpropyl)-1,4-dimethyl-7-methylidene-2,3,3a,4,5,6,6a,8,9,9b-decahydro-1H-phenalene
0
diterpenoidmetabolite00low000000
bromophycolide a
0
diterpenoid;
macrolide;
organobromine compound;
phenols;
tertiary alcohol		anti-HIV agent;
antibacterial agent;
antifungal agent;
antimalarial;
antineoplastic agent;
metabolite		00low000000
2-acetamidoglucal
0
acetamides;
glycal derivative		metabolite00low000000
diorcinol
0
aromatic ether;
phenols		fungal metabolite;
marine metabolite;
metabolite		00low000000
caribenol a
0
organic heterotetracyclic compound;
terpene lactone;
tertiary alcohol		antimalarial;
antitubercular agent;
metabolite		00low000000
halisulfate 1
0
organic molecular entitymetabolite00low000000
6-O-feruloylcatalpol
0
hydroxycinnamic acidmetabolite00low000000
grassypeptolide
0
cyclodepsipeptide;
macrocycle		antineoplastic agent;
metabolite		00low000000
essramycin
0
triazolopyrimidinesmetabolite00low000000
ainsliadimer a
0
sesquiterpene lactone;
spiro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite		00low000000
salvileucalin b
0
bridged compound;
diterpenoid;
furans;
gamma-lactone		antineoplastic agent;
metabolite		00low000000
ciliatamide a
0
caprolactams;
lipopeptide		antileishmanial agent;
metabolite		00low000000
etnangien
0
hydroxy monocarboxylic acid;
macrolide antibiotic		antibacterial agent;
metabolite		00low000000
latrunculol a
0
macrolidemetabolite00low000000
N-trans-sinapoyltyramine
0
hydroxycinnamic acidmetabolite00low000000
lycojapodine a
0
alkaloid;
bridged compound;
cyclic ketone;
lactone;
organic heterotetracyclic compound		anti-HIV-1 agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
metabolite		00low000000
epi-maslinic acid
0
dihydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory agent;
metabolite		00low000000
eoxin c4
0
eoxin;
leukotriene		metabolite00low000000
brartemicin
0
benzoate ester;
glycosyl glycoside derivative;
resorcinols		antimicrobial agent;
metabolite		00low000000
Majusculamide AB
0
amino acid amidemetabolite00low000000
7,8-dihydroxyflavanone
0
dihydroxyflavanoneantineoplastic agent;
metabolite		00low000000
antcin a
0
ergostanoidmetabolite00low000000
integric acid
0
carboxylic ester;
cyclic ketone;
dioxo monocarboxylic acid;
enal;
enone;
eremophilane sesquiterpenoid		HIV-1 integrase inhibitor;
metabolite		00low000000
vanilloloside
0
glycosidemetabolite00low000000
2,3-dihydro-3beta-O-sulfate withaferin A
0
27-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
epoxy steroid;
ergostanoid;
primary alcohol;
steroid sulfate;
withanolide		antineoplastic agent;
metabolite;
plant metabolite		00low000000
dicranin
0
acetylenic fatty acid;
long-chain fatty acid;
straight-chain fatty acid;
trienoic fatty acid		antibacterial agent;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
metabolite		00low000000
leachianone a
0
4'-hydroxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		antimalarial;
antineoplastic agent;
metabolite		00low000000
hordatine a
0
aromatic ether;
benzofurans;
dicarboxylic acid diamide;
guanidines;
phenols		adrenergic antagonist;
metabolite		00low000000
englerin a
0
cinnamate ester;
glycolate ester;
guaiane sesquiterpenoid		antineoplastic agent;
metabolite		00low000000
monanchocidin
0
organic molecular entitymetabolite00low000000
eurycomanone
0
cyclic ether;
delta-lactone;
enone;
organic heteropentacyclic compound;
pentol;
quassinoid;
secondary alcohol;
secondary alpha-hydroxy ketone;
tertiary alcohol		antimalarial;
antineoplastic agent;
metabolite		00low000000
sphaeropsidin a
0
gamma-lactonemetabolite00low000000
gardenoside
0
beta-D-glucoside;
cyclopentapyran;
enoate ester;
methyl ester;
monosaccharide derivative;
tertiary alcohol		metabolite00low000000
landomycin d
0
anthraquinonemetabolite00low000000
3alpha,12alpha-dihydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid
0
11-oxo steroid;
12alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
secondary alpha-hydroxy ketone;
steroid acid		antineoplastic agent;
metabolite		00low000000
antcin k
0
bile acidmetabolite00low000000
3alpha-hydroxy-4alpha-methylergosta-8,24(28)-dien-7,11-dione-26-oic acid
0
11-oxo steroid;
3alpha-hydroxy steroid;
7-oxo steroid;
monocarboxylic acid;
steroid acid		antineoplastic agent;
cholinergic antagonist;
metabolite;
serotonergic antagonist		00low000000
shizukaol B
0
triterpenoidmetabolite00low000000
shizukaol f
0
triterpenoidmetabolite00low000000
calicheamicin gamma(1)i
0
calicheamicin;
enediyne antibiotic;
organoiodine compound		antineoplastic agent;
metabolite		00low000000
staphyloxanthin
0
apo carotenoid triterpenoid;
D-aldohexose derivative;
fatty acid ester;
triol;
xanthophyll		antioxidant;
biological pigment;
metabolite;
virulence factor		00low000000
sm 1 peptide
0
acetate ester;
ergot alkaloid		metabolite00low000000
mycocyclosin
0
2,5-diketopiperazines;
organic heterotetracyclic compound;
polyphenol		metabolite00low000000
callipeltin a
0
cyclodepsipeptide;
guanidines;
lactone;
oligopeptide;
phenols		anti-HIV-1 agent;
antifungal agent;
metabolite		00low000000
vinylamycin
0
cyclodepsipeptide;
macrocycle;
primary alcohol		antibacterial agent;
antimicrobial agent;
metabolite		00low000000
promegestone
0
terpene lactonemetabolite00low000000
lancifodilactone g
0
cyclic ether;
diol;
enol;
gamma-lactone;
oxaspiro compound;
triterpenoid		anti-HIV agent;
metabolite		00low000000
rediocide a
0
diterpenoid;
epoxide;
ortho ester;
terpene lactone		insecticide;
metabolite		00low000000
lasiokaurin
0
kaurane diterpenoidmetabolite00low000000
longikaurin a
0
kaurane diterpenoidmetabolite00low000000
ponicidin
0
dioxanesmetabolite00low000000
(Z)-6,6',7,3'a-Diligustilide
0
butenolidemetabolite00low000000
suvanine
0
organic molecular entitymetabolite00low000000
shizukaol d
0
triterpenoidmetabolite00low000000
thailandepsin a
0
cyclodepsipeptidemetabolite00low000000
nordidemnin b
0
didemninmetabolite00low000000
4-formylaminooxyvinylglycine
0
non-proteinogenic alpha-amino acidmetabolite00low000000
platycoside e
0
triterpenoid saponinmetabolite00low000000
leuconoxine
0
alkaloidmetabolite00low000000
epidermin
0
macrocycle;
type A lantibiotic		antibacterial agent;
metabolite		00low000000
surfactin A
0
cyclodepsipeptide;
lipopeptide antibiotic;
macrocyclic lactone		antibacterial agent;
antifungal agent;
antineoplastic agent;
antiviral agent;
metabolite;
surfactant		00low000000
myriaporone 3
0
beta-hydroxy ketone;
epoxide;
lactol;
oxanes;
primary alcohol;
secondary alcohol		antineoplastic agent;
metabolite		00low000000
avenacoside b
0
beta-D-glucoside;
hexacyclic triterpenoid;
spiroketal;
steroid saponin;
tetrasaccharide derivative		metabolite00low000000
3-methylglutarylcarnitine
0
O-methylglutarylcarnitinemetabolite00low000000
pivaloylcarnitine
0
C5-acylcarnitinemetabolite00low000000
levoleucovorin
0
5-formyltetrahydrofolic acidantineoplastic agent;
metabolite		00low000000
7,8-dihydroneopterin
0
dihydropterin;
neopterins		Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite		00low000000
guanosine monophosphate
0
guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite		00low000000
2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine
0
methyl ketone;
pyrimidodiazepine		metabolite00low000000
dyspropterin
0
biopterins;
tetrahydropterin		human metabolite;
metabolite;
mouse metabolite		00low000000
2'-o-methylguanosine
0
methylguanosinemetabolite00low000000
allopurinol riboside
0
nucleoside analoguemetabolite00low000000
norclozapine
0
dibenzodiazepine;
organochlorine compound;
piperazines		delta-opioid receptor agonist;
metabolite;
serotonergic antagonist		00low000000
7-methylguanosine
0
methylguanosine;
organic cation		metabolite00low000000
3'-o-methylguanosine
0
methylguanosinemetabolite00low000000
primapterin
0
biopterinsmetabolite00low000000
7-methylinosine
0
inosines;
organic cation		metabolite00low000000
marineosin a
0
azaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles		antineoplastic agent;
metabolite		00low000000
marineosin b
0
azaspiro compound;
ether;
macrocycle;
oxaspiro compound;
pyrroles		antineoplastic agent;
metabolite		00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
tetrahydrocurcumin
0
beta-diketone;
diarylheptanoid;
polyphenol		metabolite00low000000
dichamanetin
0
diarylheptanoidmetabolite00low000000
curcumin
0
aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger		00low000000
bisdemethoxycurcumin
0
beta-diketone;
diarylheptanoid;
enone;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
metabolite		00low000000
demethoxycurcumin
0
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antineoplastic agent;
metabolite		00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
gallic acid
1
trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite		201820186.0low000010
indoleacetic acid
1
indole-3-acetic acids;
monocarboxylic acid		auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite		201820186.0low000010
melatonin
1
acetamides;
tryptamines		anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger		201820186.0low000010
n-acetylserotonin
1
acetamides;
N-acylserotonin;
phenols		antioxidant;
human metabolite;
mouse metabolite;
tropomyosin-related kinase B receptor agonist		201820186.0low000010
naringenin
1
4'-hydroxyflavanones;
trihydroxyflavanone		201820186.0low000010
phenethylamine
1
alkaloid;
aralkylamine;
phenylethylamine		Escherichia coli metabolite;
human metabolite;
mouse metabolite		201820186.0low000010
tryptamine
1
aminoalkylindole;
aralkylamino compound;
indole alkaloid;
tryptamines		human metabolite;
mouse metabolite;
plant metabolite		201820186.0low000010
5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate
1
catechin201820186.0medium000010
hydroxyindoleacetic acid
1
indole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite		201820186.0low000010
5-methoxytryptamine
1
aromatic ether;
primary amino compound;
tryptamines		5-hydroxytryptamine 2A receptor agonist;
5-hydroxytryptamine 2B receptor agonist;
5-hydroxytryptamine 2C receptor agonist;
antioxidant;
cardioprotective agent;
human metabolite;
mouse metabolite;
neuroprotective agent;
radiation protective agent;
serotonergic agonist		201820186.0low000010
7,8-dihydroxyflavone
2
dihydroxyflavoneantidepressant;
antineoplastic agent;
antioxidant;
plant metabolite;
tropomyosin-related kinase B receptor agonist		201820224.0low000011
4',7-dihydroxyflavanone
1
4'-hydroxyflavanones;
dihydroxyflavanone;
polyphenol		Brassica napus metabolite;
fungal xenobiotic metabolite		201820186.0medium000010
harmaline
1
harmala alkaloidoneirogen201820186.0low000010
octopamine
1
phenylethanolamines;
tyramines		neurotransmitter201820186.0low000010
sulforaphane
1
isothiocyanate;
sulfoxide		antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite		2002200222.0low000100
tyramine
1
monoamine molecular messenger;
primary amino compound;
tyramines		EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter		201820186.0low000010
n-methyltryptamine
1
tryptamine alkaloid;
tryptamines		metabolite201820186.0low000010
oxacillin
1
penicillinantibacterial agent;
antibacterial drug		2009200915.0low000100
ampicillin
1
beta-lactam antibiotic;
penicillin allergen;
penicillin		antibacterial drug2009200915.0low000100
gramine
1
aminoalkylindole;
indole alkaloid;
tertiary amino compound		antibacterial agent;
antiviral agent;
plant metabolite;
serotonergic antagonist		201820186.0low000010
thymol
1
monoterpenoid;
phenols		volatile oil component2009200915.0low000100
yohimbine
1
methyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist		201820186.0low000010
methyl-4-tyramine
1
tyraminesmouse metabolite201820186.0low000010
glycyrrhetinic acid
1
cyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		immunomodulator;
plant metabolite		202220222.0low000001
oleanolic acid
1
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		plant metabolite202220222.0low000001
n-methylphenethylamine
1
201820186.0low000010
erythromycin
1
cyclic ketone;
erythromycin		2009200915.0low000100
vancomycin
1
glycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite		2009200915.0low000100
tabersonine
1
alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		antineoplastic agent;
metabolite		201820186.0low000010
paclitaxel
1
taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent		2007200717.0low000100
nelfinavir
1
aryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound		antineoplastic agent;
HIV protease inhibitor		202120213.0low000001
betulinic acid
1
hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite		201820186.0low000010
arctigenin
1
lignan2007200717.0low000100
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose
1
gallate ester;
galloyl beta-D-glucose		anti-inflammatory agent;
antineoplastic agent;
geroprotector;
hepatoprotective agent;
plant metabolite;
radiation protective agent;
radical scavenger		201820186.0low000010
pinocembrin
2
(2S)-flavan-4-one;
dihydroxyflavanone		antineoplastic agent;
antioxidant;
metabolite;
neuroprotective agent;
vasodilator agent		2006200717.5low000200
epicatechin
1
catechin;
polyphenol		antioxidant202120213.0low000001
narciclasine
1
phenanthridinesmetabolite202220222.0low000001
pinostrobin
3
monohydroxyflavanone;
monomethoxyflavanone		antidote;
plant metabolite		2002200719.0high000300
isoalantolactone
1
eudesmane sesquiterpenoid;
sesquiterpene lactone		antifungal agent;
apoptosis inducer;
plant metabolite		202220222.0low000001
maslinic acid
2
dihydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite		201820224.0low000011
asperuloside
1
acetate ester;
beta-D-glucoside;
gamma-lactone;
iridoid monoterpenoid;
monosaccharide derivative		metabolite202220222.0low000001
quindoline
1
201820186.0low000010
diphyllin
1
lignan202220222.0low000001
tryptoline
1
beta-carbolines201820186.0low000010
tanshinone
1
abietane diterpenoidanticoronaviral agent202220222.0low000001
pumiliotoxin c
1
201820186.0low000010
diazaquinomycin a
1
quinolone201820186.0medium000010
celastrol
1
monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite		202220222.0low000001
fraxinellone
1
2-benzofurans201820186.0low000010
glabridin
2
hydroxyisoflavansantiplasmodial drug201820224.0low000011
6-bromo-3-(bromomethyl)-7-methyl-2,3,7-trichloro-1-octene
1
monoterpenoid;
organobromine compound;
organochlorine compound		algal metabolite;
antineoplastic agent;
marine metabolite		201820186.0medium000010
levofloxacin
1
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor		2009200915.0low000100
pseudonicotine
1
3-(1-methylpyrrolidin-2-yl)pyridine201820186.0low000010
deferrioxamine e
1
cyclic desferrioxamine;
cyclic hydroxamic acid;
macrocycle		antineoplastic agent;
bacterial metabolite;
marine metabolite;
siderophore		201820186.0low000010
4'-hydroxyflavanone
1
4'-hydroxyflavanones;
monohydroxyflavanone		201820186.0low000010
lupeol
1
pentacyclic triterpenoid;
secondary alcohol		anti-inflammatory drug;
plant metabolite		201820186.0low000010
withaferin a
1
27-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
enone;
epoxy steroid;
ergostanoid;
primary alcohol;
secondary alcohol;
withanolide		antineoplastic agent;
apoptosis inducer		202220222.0low000001
crinine
1
alkaloid201820186.0low000010
strychnine
1
monoterpenoid indole alkaloid;
organic heteroheptacyclic compound		avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide		201820186.0low000010
hyperforin
1
202220222.0low000001
linezolid
1
acetamides;
morpholines;
organofluorine compound;
oxazolidinone		antibacterial drug;
protein synthesis inhibitor		2009200915.0low000100
micheliolide
1
sesquiterpene lactone201820186.0low000010
pancracine
1
isoquinoline alkaloid fundamental parent;
isoquinoline alkaloid		201820186.0low000010
ferulic acid
1
ferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite		201820186.0low000010
ganoderic acid a
1
triterpenoid202220222.0medium000001
4-hydroxypanduratin a
2
2006200717.5high000200
piperine
1
benzodioxoles;
N-acylpiperidine;
piperidine alkaloid;
tertiary carboxamide		food component;
human blood serum metabolite;
NF-kappaB inhibitor;
plant metabolite		201820186.0low000010
trichodermamide b
1
201820186.0medium000010
cardamonin
2
chalcones2006200717.5low000200
benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester
1
benzoate ester202120213.0medium000001
helvolic acid
1
3-oxo-Delta(1) steroid;
acetate ester;
monocarboxylic acid;
steroid acid		antibacterial agent;
fungal metabolite;
mycotoxin		201820186.0low000010
mitragynine
1
monoterpenoid indole alkaloid201820186.0low000010
paynantheine
1
201820186.0medium000010
chimonanthine
1
chimonanthine201820186.0low000010
1,8-dinitro-4,5-dihydroxyanthraquinone
1
202120213.0medium000001
tolcapone
1
2-nitrophenols;
benzophenones;
catechols		antiparkinson drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor		202120213.0low000001
3-deoxyisoochracinic acid
1
201820186.0high000010
5,6-dehydrokawain
1
2-pyranones;
aromatic ether		2007200717.0low000100
formononetin
1
4'-methoxyisoflavones;
7-hydroxyisoflavones		phytoestrogen;
plant metabolite		202220222.0low000001
luteolin-7-glucoside
1
beta-D-glucoside;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone		antioxidant;
plant metabolite		201820186.0low000010
rutin
1
disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone		antioxidant;
metabolite		201820186.0low000010
harmine
1
harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite		201820186.0low000010
butein
1
chalcones;
polyphenol		antineoplastic agent;
antioxidant;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
geroprotector;
hypoglycemic agent;
plant metabolite;
radiosensitizing agent;
tyrosine kinase inhibitor		202220222.0low000001
baicalein
1
trihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger		201820186.0low000010
fisetin
1
3'-hydroxyflavonoid;
7-hydroxyflavonol;
tetrahydroxyflavone		anti-inflammatory agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
metabolite;
plant metabolite		201820186.0low000010
wogonin
1
dihydroxyflavone;
monomethoxyflavone		angiogenesis inhibitor;
antineoplastic agent;
cyclooxygenase 2 inhibitor;
plant metabolite		201820186.0low000010
tectochrysin
1
monohydroxyflavone;
monomethoxyflavone		antidiarrhoeal drug;
antineoplastic agent;
plant metabolite		2007200717.0low000100
3',4',7-trihydroxyisoflavone
1
7-hydroxyisoflavonesantineoplastic agent;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor;
metabolite		202220222.0low000001
peridinin
1
202120213.0low000001
cytochalasin b
1
cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor		201820186.0low000010
corylin
1
202220222.0low000001
kaempferol 3-o-rhamnoside
1
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone		anti-inflammatory agent;
antibacterial agent;
plant metabolite		201820186.0low000010
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one
1
dihydroxyflavone;
monomethoxyflavone		antineoplastic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor		201820186.0low000010
flavokawain b
1
chalcones;
dimethoxybenzene;
phenols		anti-inflammatory agent;
antileishmanial agent;
antineoplastic agent;
apoptosis inducer;
metabolite		2002200222.0low000100
radicinin
1
aromatic ketone201820186.0low000010
calycanthine
1
aminal;
calycanthaceous alkaloid;
organonitrogen heterocyclic compound		201820186.0low000010
xanthoepocin
1
201820186.0high000010
3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one
1
coumarinsgeroprotector202220222.0low000001
flavokawain C
1
chalcones2007200717.0low000100
22,23-dihydroavermectin b(1)a
1
macrocyclic lactone;
spiroketal		202120213.0low000001
herboxidiene
1
201820186.0low000010
(1Ar,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one
1
germacranolide201820186.0medium000010
(3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone
1
oligopeptide201820186.0low000010
13-epi-sclareol
1
201820186.0low000010
n,n-(4-xylylidene)bisaminoguanidine
1
202120213.0medium000001
selamectin
1
milbemycin202120213.0medium000001
lipstatin
1
202220222.0low000001
gentamicin sulfate
1
2009200915.0low000100
isopanduratin a
1
2007200717.0medium000100
akuammicine
1
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		plant metabolite201820186.0low000010
hermitamide b
1
201820186.0medium000010
trans-delta-tocotrienoloic acid
1
tocotrienol201820186.0low000010
nodulisporic acid a
1
201820186.0low000010
scopadulcic acid b
1
201820186.0low000010
gliocladin c
1
201820186.0low000010
zincophorin
1
pyransbacterial metabolite;
ionophore		201820186.0low000010
streptazolin
1
201820186.0low000010
chatancin
1
201820186.0medium000010
morelloflavone
1
biflavonoid;
hydroxyflavanone;
hydroxyflavone		plant metabolite201820186.0low000010
cinnamosmolide
1
201820186.0medium000010
oplodiol
1
carbobicyclic compound;
octahydronaphthalenes;
secondary alcohol;
sesquiterpenoid;
tertiary alcohol		plant metabolite2002200222.0medium000100
astragaloside IV
1
pentacyclic triterpenoid;
triterpenoid saponin		anti-inflammatory agent;
antioxidant;
EC 4.2.1.1 (carbonic anhydrase) inhibitor;
neuroprotective agent;
plant metabolite;
pro-angiogenic agent		202220222.0high000001
15-deoxygoyazensolide
1
201820186.0medium000010
mitragynine
1
201820186.0medium000010
tannins
1
tannin202120213.0low000001
spongia-13(16),14-dien-19-oic acid
1
cyclic ether;
monocarboxylic acid;
tetracyclic diterpenoid		androgen antagonist;
metabolite		201820186.0medium000010
roquefortine
1
pyrroloindole201820186.0high000010
3-(3,4-dihydroxyphenyl)lactate
1
hydroxy monocarboxylic acid anion201820186.0medium000010
marinopyrrole a
1
aromatic ketone;
organochlorine compound;
phenols;
pyrroles		antibacterial agent;
antimicrobial agent;
antineoplastic agent;
bacterial metabolite;
marine metabolite		201820186.0low000010
colletoic acid
1
201820186.0medium000010
ipomoeassin f
1
201820186.0low000010
6,8-dihydroxy-2,2,4,4-tetramethyl-7-(3-methylbutanoyl)-9-(2-methylpropyl)-9h-xanthene-1,3-dione
1
xanthenes201820186.0high000010
7-hydroxymitragynine
1
alkaloid201820186.0low000010
dorrigocin b
1
201820186.0medium000010
dorrigocin a
1
201820186.0low000010
tatanan a
1
201820186.0medium000010
tetracycline
1
2009200915.0low000100
ilicicolin h
1
aromatic ketone;
carbobicyclic compound;
ilicicolin;
monohydroxypyridine;
octahydronaphthalenes;
phenols;
pyridone		antimicrobial agent;
mitochondrial respiratory-chain inhibitor		201820186.0low000010
tatanan b
1
201820186.0high000010
gracilioether f
1
201820186.0medium000010
cryptocaryol a
1
2-pyranones;
pentol		plant metabolite201820186.0medium000010
tetrahydroamentoflavone
1
201820186.0high000010
nataxazole
1
201820186.0high000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
chlorine
1
halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite		202220222.0low000001
gallic acid
1
trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite		201520159.0low000010
histamine
1
aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter		2012201212.0low000010
tert-butylhydroperoxide
1
alkyl hydroperoxideantibacterial agent;
oxidising agent		2005200519.0low000100
2-methylpentane
1
alkane201520159.0low000010
catechin
1
catechinantioxidant;
plant metabolite		2011201113.0low000010
malondialdehyde
1
dialdehydebiomarker2013201311.0low000010
silver
1
copper group element atom;
elemental silver		Escherichia coli metabolite2010201014.0low000100
tetradecanoylphorbol acetate
1
acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator		2012201212.0low000010
octyl gallate
1
gallate esterfood antioxidant;
hypoglycemic agent;
plant metabolite		201520159.0low000010
xanthorrhizol
1
sesquiterpenoid201520159.0low000010
1,2-hexanediol
1
201520159.0low000010
epicatechin gallate
1
catechin;
gallate ester;
polyphenol		EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite		2011201113.0low000010
lignans
1
201520159.0low000010
4-hydroxypanduratin a
1
2014201410.0medium000010
chalcone
2
chalconeEC 3.2.1.1 (alpha-amylase) inhibitor201120227.5low000011
2'-hydroxychalcone
1
chalcones;
phenols		anti-inflammatory agent2010201014.0low000100
oxazolone
1
2014201410.0low000010
thioguanine anhydrous
1
2-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent		201920195.0low000010
thioacetamide
2
thiocarboxamidehepatotoxic agent201320188.5low000020
1,1-diphenyl-2-picrylhydrazyl
1
2013201311.0low000010
osteoprotegerin
1
long-chain fatty acid201820186.0low000010
dinoprostone
1
prostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic		2003200321.0low000100
leukotriene b4
1
dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid		human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent		2012201212.0low000010
chlorhexidine
1
biguanides;
monochlorobenzenes		antibacterial agent;
antiinfective agent		2009200915.0low000100
macelignan
1
lignan201520159.0low000010
calcimycin
1
benzoxazole2012201212.0low000010
colistin
1
202220222.0low000001
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
2019 Novel Coronavirus Disease0
1
202320231.0low000001
Acute Kidney Failure0
1
202120213.0low000001
Acute Kidney Injury0
1
202120213.0low000001
Alveolar Bone Atrophy0
1
201820186.0low000010
Atopic Hypersensitivity0
1
2012201212.0low000010
Atrophy, Muscle0
1
201720177.0low000010
Basophilic Leukemia, Acute0
1
2012201212.0low000010
Body Weight0
1
202220222.0low000001
Break-Bone Fever0
1
2014201410.0low000010
Cancer of Colon0
1
2005200519.0low000100
Cancer of Lung0
1
2013201311.0low000010
Cancer of Pancreas0
1
2007200717.0low000100
Cancer of Prostate0
1
2011201113.0low000010
Cancer of Skin0
1
201520159.0low000010
Carcinoma0
1
2009200915.0low000100
Carcinoma, Anaplastic0
1
2009200915.0low000100
Carcinoma, Hepatocellular0
1
2002200222.0low000100
Carcinoma, Non-Small Cell Lung0
1
2013201311.0low000010
Carcinoma, Non-Small-Cell Lung0
1
2013201311.0low000010
Cirrhoses, Experimental Liver0
1
201820186.0low000010
Colonic Neoplasms0
1
2005200519.0low000100
Congenital Zika Syndrome0
1
202020204.0low000010
Cyst0
1
202220222.0low000001
Dengue0
1
2014201410.0low000010
Dental Plaque0
1
2009200915.0low000100
Dermatitis, Atopic0
1
2014201410.0low000010
Disease Models, Animal0
2
202020223.0low000011
Eczema, Atopic0
1
2014201410.0low000010
Hepatocellular Carcinoma0
1
2002200222.0low000100
Inflammation0
2
201820224.0low000011
Innate Inflammatory Response0
2
201820224.0low000011
Kidney Diseases0
1
202220222.0low000001
Kidney, Polycystic0
1
202220222.0low000001
Leukemia, Basophilic, Acute0
1
2012201212.0low000010
Lung Neoplasms0
1
2013201311.0low000010
Malignant Melanoma0
2
201520187.5low000020
Melanoma0
2
201520187.5low000020
Muscular Atrophy0
1
201720177.0low000010
Obesity0
2
201120227.5low000011
Pancreatic Neoplasms0
1
2007200717.0low000100
Parodontosis0
1
201820186.0low000010
Pericementitis0
4
200920226.8low000121
Periodontal Diseases0
1
201820186.0low000010
Periodontitis0
4
200920226.8low000121
Polycystic Kidney Diseases0
1
202220222.0low000001
Prostatic Neoplasms0
1
2011201113.0low000010
Skin Aging0
2
2008201711.5low100110
Skin Neoplasms0
1
201520159.0low000010
Zika Virus Infection0
1
202020204.0low000010

Safety/Toxicity (1)

ArticleYear
Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium.
Journal of natural products, , Volume: 70, Issue:10		2007

Pharmacokinetics (1)

ArticleYear
Pharmacokinetics of panduratin A following oral administration of a Boesenbergia pandurata extract to rats.
Journal of food and drug analysis, , 12-15, Volume: 29, Issue:4		2021

Bioavailability (1)

ArticleYear
Absolute oral bioavailability and possible metabolic pathway of panduratin A from
Pharmaceutical biology, , Volume: 61, Issue:1		2023